Abstract
The endoplasmic reticulum (ER) employs a diverse proteome landscape to orchestrate many cellular functions, ranging from protein and lipid synthesis to calcium ion flux and inter-organelle communication. A case in point concerns the process of neurogenesis, where a refined tubular ER network is assembled via ER shaping proteins into the newly formed neuronal projections to create highly polarized dendrites and axons. Previous studies have suggested a role for autophagy in ER remodelling, as autophagy-deficient neurons in vivo display axonal ER accumulation within synaptic boutons, and the membrane-embedded ER-phagy receptor FAM134B has been genetically linked with human sensory and autonomic neuropathy. However, our understanding of the mechanisms underlying selective removal of the ER and the role of individual ER-phagy receptors is limited. Here we combine a genetically tractable induced neuron (iNeuron) system for monitoring ER remodelling during in vitro differentiation with proteomic and computational tools to create a quantitative landscape of ER proteome remodelling via selective autophagy. Through analysis of single and combinatorial ER-phagy receptor mutants, we delineate the extent to which each receptor contributes to both the magnitude and selectivity of ER protein clearance. We define specific subsets of ER membrane or lumenal proteins as preferred clients for distinct receptors. Using spatial sensors and flux reporters, we demonstrate receptor-specific autophagic capture of ER in axons, and directly visualize tubular ER membranes within autophagosomes in neuronal projections by cryo-electron tomography. This molecular inventory of ER proteome remodelling and versatile genetic toolkit provide a quantitative framework for understanding the contributions of individual ER-phagy receptors for reshaping ER during cell state transitions.
Similar content being viewed by others
Main
The endoplasmic reticulum (ER) network is shaped by proteins that promote tubule and sheet-like membrane structures, which in turn tailors ER function in a cell-type-specific manner to optimize protein secretion, calcium storage, lipid homeostasis and inter-organelle contacts1,2,3,4. ER-phagy is a mechanism through which ER can be remodelled, or superfluous ER proteins or lipids recycled5,6,7. Membrane-bound ER-phagy receptors include single-pass transmembrane (TM) segment containing proteins TEX264, CCPG1, SEC62 and reticulon-like hairpin domain (RHD) containing proteins FAM134A, B and C (also called RETREG2, 1, 3, respectively), Atlastin (ATL2) and RTN3L7,8,9,10,11,12,13,14,15. RHDs reside in the outer leaflet of the ER membrane to induce curvature16,17,18. All ER-phagy receptors contain cytosolic LC3-interaction region (LIR) motifs that bind to ATG8 proteins such as MAP1LC3B (also called LC3B) on the phagophore to promote ER capture5. The FAM134 class of receptors are thought to cluster through their hairpin RHDs into highly curved nanoscale membrane domains that recruit the autophagy machinery, thereby nucleating phagophore formation5,6,19,20,21. Phagophore closure around the ER is thought to be coupled to scission of the ER membrane, although the mechanism is unknown.
Central unanswered questions in the field include when, where and how individual receptors are used to remodel the ER during physiological changes in the cell state. In addition, the identity of ER-phagy ‘cargos’ in unique cell states is poorly understood. Although ER protein accumulation has been observed in ATG5−/− mouse synaptic boutons22, this was attributed to non-selective autophagy rather than selective ER-phagy22. An understanding of ER-phagy is further confounded by ER membranes both serving as a source of phospholipids for autophagosome expansion23 and as being captured as cargo within a fully formed autophagosome via selective ER-phagy, as visualized by electron microscopy9,10. However, critical work has revealed that the process of lipid transfer from the ER to the growing autophagosome occurs without the incorporation of ER proteins into the phagophore membrane itself23,24. Thus, the process of ER-phagy receptor-facilitated ER protein clearance is functionally and mechanistically distinct from the use of ER membranes as a source for phospholipids in phagophore expansion.
In this Article we employ an in vitro neurogenesis system that recapitulates central autophagy-dependent features of ER remodelling25 to directly examine the role of ER-phagy receptors in this process. We identify redundant and selective ER-phagic cargo for individual receptors, demonstrate a role for multiple ER-phagy receptors in eliminating axonal ER, directly visualize ER-phagy receptors trafficking in autophagosomes in axons, and visualize tubular ER membranes captured within autophagosomes in neuronal projections via cryo-electron tomography (cryo-ET). We find that ER protein remodelling by autophagy during neurogenesis facilitates a continuum of small abundance changes in individual ER-resident proteins. We implement a quantitative proteomic framework capable of measuring and classifying these abundance changes across the ER proteome in the context of an allelic series of ER-phagy receptor mutants. We find that FAM134 family members play a dominant and largely redundant role in remodelling ER membrane proteins during neurogenesis, whereas CCPG1 is primarily responsible for autophagic turnover of lumenal ER proteins, thereby defining an underlying specificity for ER remodelling. These data provide a proteomic landscape for ER remodelling in induced neurons (iNeurons) and an experimental framework for elucidating how changes in cell state control the ER proteome via selective autophagy.
Results
ER remodelling by autophagy during in vitro neurogenesis
To examine the alterations in abundance for approximately 350 ER proteins26 (Extended Data Fig. 1a and Supplementary Table 1), we initially mined proteome abundance measurements from our previous human embryonic stem cell (hESC) neurogenesis resource25 (Fig. 1a). During a 12-day iNeuron differentiation, a diverse cohort of ER proteins within multiple functional categories increase or decrease in abundance (Fig. 1a,b, Extended Data Fig. 1b and Supplementary Table 2)25. Proteins undergoing the largest increase in abundance include enzymes involved in protein folding (for example, FKBP9), ion regulation (for example, RCN1) and collagen modification (for example, COL4A2), whereas other collagen-modifying proteins (PXDN and P3H4) decrease in abundance (Fig. 1a). The ER-shaping RHD proteins RTN1, RTN4 and REEP2 displayed the largest increase in abundance, with a greater than 1.4-fold increases from day-0 levels (that is, a log2(fold change day 12 versus day 0) greater than 0.5, more simply shown as log2FC > 0.5; Fig. 1b and Extended Data Fig. 1b). This is consistent with the formation of ER tubule networks within neuronal projections, as previously characterized27. Indeed, immunofluorescence revealed extensive α-RTN4-positive projections in iNeurons, while the ER sheet protein CKAP4 (also called CLIMP63) was largely confined to the soma (Extended Data Fig. 1c).
We next compared wildtype (WT) and ATG12−/− day-12 iNeurons using tandem mass tagging (TMT) proteomics (Fig. 1c and Supplementary Table 3). ATG12 is conjugated to ATG5 to support lipidation of ATG8 proteins. Consistent with reduced autophagic clearance25, ubiquitin-binding autophagy receptors (CALCOCO1, CALCOCO2, TAX1BP1) and the ATG8 protein GABARAPL2 accumulated in ATG12-deficient iNeurons, as did the ER-phagy receptors TEX264 and FAM134A (>1.4-fold change, log2FC > 0.49; Fig. 1c). Moreover, a cohort of ER proteins displayed increased abundance, as indicated by the rightward skew distribution in volcano plots of log2FC values for ATG12−/−/WT proteomes. Similarly, violin plots revealed an overall increase in ER protein abundance, which showed a mean log2FC of 0.33 (1.26-fold increase across all ER proteins; Fig. 1c,d and Extended Data Fig. 1d). Strikingly, RHD proteins accumulate to the greatest degree (including REEP1–4 and RTN1), whereas the ER sheet proteins CKAP4 and RRBP1 were unchanged (Fig. 1d–f). Alterations in abundance for TEX264, REEP5 and CKAP4 were verified by immunoblotting, as was the increased abundance of FAM134C (not detected by proteomics in this experiment; Extended Data Fig. 1e,f). Mapping the landscape of ER protein accumulation in ATG12 deletion iNeurons (log2FC from WT) revealed that, beyond ER curvature-shaping proteins, specific ER proteins assigned to several other structural or functional categories accumulate during differentiation in the absence of autophagy, including lumenal and TM segment-containing biosynthetic or metabolic proteins (Extended Data Fig. 1a). The differentiation efficiency of ATG12−/− iNeurons was equivalent to WT iNeurons as assessed by the induction or loss of several differentiation/pluripotency factors (Extended Data Fig. 2a and Supplementary Table 4). Moreover, ATG12−/− iNeuron viability was equivalent to WT iNeurons (Extended Data Fig. 2b–d). We also examined whether ATG12 deficiency promotes ER stress, but detected no increase in the ER stress response markers ATF4 (protein level expression) or XBP-1 (mRNA splicing) when compared with WT iNeurons, although tunicamycin treatment induced both ATF4 expression and XBP-1 splicing (Extended Data Fig. 2e,f). Thus, in vitro neurogenesis without autophagy is associated with alterations in the abundance of the ER proteome.
Aberrant axonal ER accumulation in ATG12−/− neurogenesis
We next examined ER morphology in WT or ATG12−/− day-20 iNeurons using α-calnexin or α-RTN4 as general or tubule-enriched markers for ER, respectively. We observed ER-positive accumulations that dilated the projections in autophagy-deficient cells that were larger and more numerous than seen in WT iNeurons (Fig. 2a–e). α-NEFH (high-molecular-weight neurofilament-H) staining verified that the dilations were present within axons, with NEFH filaments encasing ER dilations (Fig. 2b, inset). The mean area of ER accumulations dilating the axons in ATG12−/− iNeurons was 12.2 μm2, whereas in WT iNeurons these were less abundant and consistently smaller (mean area, 6.3 μm2) (Fig. 2c–e). Consistent with light microscopy, scanning transmission electron microscopy (TEM) revealed frequent dilated ER-rich bulbous structures in ATG12−/− iNeurons adjacent to continuous microtubules that were rare and smaller in WT processes (Fig. 2f,g). These ER-rich dilations are reminiscent of the previously observed axon boutons within mouse neurons lacking Atg522.
ER-phagic flux during differentiation and in iNeurons
We next measured the extent to which certain ER proteins were cleared from the ER membrane to acidic lysosomes via autophagy, which we define here as ER-phagic flux. We measured ER-phagic flux at different stages of differentiation and in post-differentiated ‘established’ iNeurons using a pH-sensitive Keima reporter localized throughout the ER (Keima-RAMP4, a pan-ER reporter widely used in the ER-phagy field; Fig. 3a) or a reporter localized selectively in ER tubules (Keima-REEP5; Fig. 3b). More specifically, our ER-phagy flux readout was derived from a ratiometric comparision of acidified Keima-ER within lysosomes with non-acidified Keima-ER throughout the ER network9,13,28. Neither reporter underwent significant flux in hESCs, consistent with the absence of ER protein accumulation in ATG12−/− hESCs25. However, during differentiation, we observed an increase in acidic Keima signal (increased acidic/neutral ratio, as defined in the Methods) for both ER reporters, with acidified puncta representing ER in lysosomes located primarily in the soma (Fig. 3a,b). Parallel flow cytometry experiments quantified the amount of ER flux to lysosomes upon differentiation using both reporters (Fig. 3c,d). Acidic signal was normalized to cells treated with bafilomycin A (BAFA, 4 h), which inhibits lysosomal acidification. This ER flux was reduced in cells lacking ATG12, and residual flux was eliminated by addition, throughout the differentiation time course, of the VPS34 PI3 kinase inhibitor SAR405 (VPS34i), which blocks phagophore initiation (Fig. 3e,f). The detectable flux in ATG12−/− cells is consistent with the previous finding that loss of the ATG8 conjugation system does not fully block autophagosome formation29. Due to the long half-life of Keima in lysosomes30, detectable stable Keima within lysosomes over multiple days of differentiation was expected. Release from continuous VPS34 inhibition one or two days before (at day 10 or 11) iNeuron collection (at day 12) resulted in increased ER-phagic flux comparable to that of untreated cells; this increase was absent in cells lacking ATG12 (Fig. 3f). Finally, we examined whether ER-phagic flux was ongoing in established iNeurons. Keima flux measured in later-stage day-20 neurons was reduced by adding VPS34i at day 15 of differentiation, as compared with untreated cells (Fig. 3g). These results indicate that ER fluxes to lysosomes during differentiation in a process that requires canonical autophagy, and that autophagic ER flux is ongoing in established iNeurons.
Receptor capture by autophagosomes in axons and somata
It is well known that autophagosomes can form in axons, and subsequently fuse with lysosomes, which acidify during retrograde trafficking en route to the soma31,32,33. Thus, ATG12-dependent acidic Keima-RAMP4-positive puncta in the soma (Fig. 3a,b,h) could reflect ER-phagy occurring locally in the soma or, alternatively, axonal ER-phagic capture within autophagosomes followed by retrograde transport to the soma with concomitant acidification.
To examine the spatial aspects of ER-receptor capture, we expressed TEX264-GFP or FAM134C-GFP in iNeurons (Extended Data Fig. 2g,h). Previous studies have demonstrated that TEX264 and FAM134 proteins can localize broadly throughout the ER network and can form coincident puncta that become engulfed by autophagosomes7,9. We observed TEX264-GFP punctate structures (indicated by arrowheads) both in projections and in the soma (day 4 of differentiation) that were rarely detected: (1) when TEX264’s LIR motif was mutated (F273A), (2) in ATG12−/− cells or (3) in VPS34i-treated cells (Extended Data Fig. 2g–i). Thus, ER-phagy receptor puncta formation in iNeurons was probably due to active ER-phagy, as described in other cell systems with starvation as a trigger for ER-phagy7,9.
To verify TEX264-GFP puncta in autophagic structures, we co-expressed mCherry-LC3B (mCh-LC3B). Co-staining with α-NEFH in fixed cells verified the coincidence of mCh-LC3B and TEX264-GFP in axons (Extended Data Fig. 2j). We took advantage of the highly polarized axons in day-30 iNeurons to track the movement of mCh-LC3B/TEX264-GFP-positive puncta. Numerous GFP-TEX264 puncta trafficked with mCh-LC3-positive structures (Fig. 4a,b and Supplementary Video 1). Autophagosomes enriched in TEX264 moved unidirectionally (predominant movement in one direction on the track is defined here as ‘forward’), but we also recorded stops and some backward movements on these tracks (Fig. 4c). The median forward speed was 0.297 μm s−1 (Fig. 4c), similar to the speeds reported for autophagosomes undergoing microtubule-dependent trafficking in axons of mouse primary neurons34. Similarly, FAM134C-GFP-positive structures trafficking with mCh-LC3B puncta were also observed in day-30 iNeurons (Fig. 4d and Supplementary Video 2), indicating that multiple ER-phagy receptors may be operating within projections.
We next examined whether ER-rich axonal dilations might be sites of ER-phagic capture. Indeed, live-cell imaging revealed TEX264-GFP/mCh-LC3B-positive puncta emerging from axonal dilations in WT iNeurons (Fig. 4e and Supplementary Video 3). In contrast, although TEX264-GFP was present in regions with dilated axonal ER in ATG12−/− iNeurons, TEX264-GFP/mCh-LC3B-positive puncta were not observed (Fig. 4e). These data suggest a role for ER-phagy receptor-dependent clearance of ER in axonal processes.
ER within autophagosomes in neuronal projections by cryo-ET
TEX264-GFP/mCh-LC3B trafficking led us to ask whether ER-containing autophagosomes could be visualized in projections by cryo-ET. iNeurons grown on EM grids were plunge-frozen at day 18, followed by cryo-fluorescence microscopy and cryo-ET of thin neuronal projections (Fig. 5a). We used an unbiased approach to survey axonal projections for autophagic structures, which we identified directly in TEM images. We then correlated autophagosome positions in the TEM images with cryo-fluorescence data to evaluate coincidence with fluorescence signal. Finally, neural network-based segmentation revealed the cargo and cellular surroundings of the captured autophagosomes, yielding 37 autophagosomes captured in situ in projections (Fig. 5b–h, Extended Data Fig. 3a–f and Methods). Many autophagic structures (24 out of 37) were proximal to microtubules within the axon, as would be expected during trafficking to the soma (Fig. 5c–h and Extended Data Fig. 3d,f). Interestingly, tubular ER is present as cargo inside 21 of the 37 autophagosomes analysed (Fig. 5b–h, Extended Data Fig. 3e,f and Supplementary Video 4), and regions with GFP signal were coincident with ER tubule-containing autophagic structures (Fig. 5b,d,g and Extended Data Fig. 3g–n). In particular, five out of 21 ER tubule-containing autophagic structures coincided with a TEX264-GFP signal, and four of the five were adjacent to microtubules. Absence of GFP-TEX264 signal in a subset of ER-containing autophagosomes may be due to a low expression level of lentiviral-transduced TEX264-GFP in individual iNeurons or due to selective capture by alternative ER-phagy receptors. Although TEX264-GFP displayed a punctate and distinct signal, the mCh-LC3B cryo-fluorescence signal appeared diffuse and could not be reliably used for correlation (Extended Data Fig. 3m and Methods). Notably, autophagosomes that did not contain tubular ER cargo never coincided with TEX264-GFP signal (Fig. 5b). Together, these data confirm capture of TEX264-GFP-positive ER by autophagy within axons and demonstrate selective ER-phagy in iNeurons.
A genetic toolkit for ER-phagy receptor analysis in iNeurons
To systematically explore the contributions of individual ER-phagy receptors to ER remodelling during iNeuron differentiation35, we used gene editing to create single-knockout hESCs for FAM134A, FAM134B, FAM134C, TEX264 or CCPG1, which were confirmed by sequence analysis and immunoblotting (Fig. 6a and Extended Data Fig. 4a,b). To address redundancy among the ER-phagy receptors10, we sequentially edited FAM134C−/− cells to create double, triple, quadruple and penta receptor knockout lines: FAM134A/C−/− (DKO), FAM134A/B/C−/− (TKO), FAM134A/B/C/TEX264−/− (QKO) and FAM134A/B/C/TEX264/CCPG1−/− (PKO) (Fig. 6b and Extended Data Fig. 4c,d). Sequential deletion of ER-phagy receptors was verified by sequence analysis and immunoblotting; QKO and PKO mutants displayed normal karyotypes (Extended Data Fig. 4c–e). PKO iNeurons differentiated efficiently, displayed viability parameters equivalent to WT iNeurons, and displayed no evidence of ER stress as assessed by ATF4 or XBP1s induction (Extended Data Fig. 2a–f and Supplementary Table 4). Each mutant cell line was reconstituted with Keima-RAMP4 to measure ER-phagic flux (Fig. 6a,b).
ER-phagy receptor control of ER-phagic flux in iNeurons
To examine individual receptor contributions to ER-phagy during differentiation, we measured Keima-RAMP4 flux in receptor mutant cells at day 0, 4 or 12 of differentiation using flow cytometry (Fig. 6c and Extended Data Fig. 4f,g). As expected, the Keima-RAMP4 flux increased from 2.5- to 4.0-fold in WT cells at days 4 and 12 of differentiation, which was substantially reduced in day-12 ATG12−/− iNeurons (Fig. 6c and Extended Data Fig. 4f,g). All single mutants displayed Keima-RAMP4 flux comparable to WT at day 4 and >80% of WT at day 12 (Fig. 6c and Extended Data Fig. 4g). However, upon elimination of FAM134A/C, the level of Keima-RAMP4 flux approached that seen with ATG12−/− cells at day 12 of differentiation, with a slight further reduction upon removal of additional receptors (Fig. 6d). Importantly, the reduction in ER-phagic flux measured for ATG12−/− and PKO iNeurons was not skewed due to differential cell viability (Extended Data Fig. 4h).
Consistent with defective ER turnover, day-20 PKO iNeurons displayed more abnormally enlarged α-calnexin-marked ER structures in α-NEFH-positive axons (Fig. 6e). The number and size of these structures were intermediate between WT and ATG12−/− iNeurons (Fig. 6f). TEM of thin sections through axons of PKO iNeurons also revealed examples of frequent dilated structures rich in tubular ER, albeit smaller than that observed in ATG12−/− axons (Fig. 6g and Extended Data Fig. 4i).
Combinatorial receptor control of the neuronal ER proteome
We next sought to define how the entire ER proteome is remodelled by individual ER-phagy receptors during differentiation and to unmask the potential selectivity of receptors for specific clients. We performed 18-plex TMT quantitative proteomics using single (Fig. 7a and Supplementary Table 5) and combinatorial (Fig. 7b and Supplementary Table 3) ER-phagy receptor mutants at day 12 of differentiation. ATG12−/− iNeurons were included as a control for autophagy-dependent stabilization. The abundance of organelles at the global level, including ER, was largely unaffected in single ER-phagy mutants, as suggested by violin plots for individual organelle proteomes (Fig. 7a and Extended Data Fig. 5a). In contrast, and consistent with a more pronounced effect on Keima-RAMP4 flux and axonal ER accumulation, combinatorial mutants displayed an overall increase in ER protein abundance comparable to that seen in ATG12−/− (Fig. 7b–c and Extended Data Fig. 5b–d). The distribution of ER proteins in ATG12−/− or the DKO to PKO mutants significantly deviates from a randomized selection of proteins (randomized control) of the same number of proteins (Fig. 7c). However, the combinatorial mutants did not affect the distribution of the Golgi proteome, known to be regulated by loss of ATG12 in this system25,36, consistent with a specific role of ER-phagy receptors in ER turnover (Extended Data Fig. 5b–d). Importantly, we confirmed, using quantitative proteomics, that ER protein accumulation was maintained in later-stage day-20 ATG12−/− and PKO iNeurons, corresponding to the time employed for several imaging experiments described above, and we confirmed that this ER accumulation occurs in an independent PKO clone (Extended Data Fig. 6a–c and Supplementary Table 6).
In cancer cell lines, MTOR inhibitor Torin1 induces a starvation-like response, leading to clearance of ER (among other organelles) and proteins via autophagy37. To further probe the susceptibility of ER to selective turnover via general autophagy as compared to selective ER-phagy, we examined the organelle and proteome abundance in iNeurons treated with Torin1 for 15 h. In ATG12−/− iNeurons, organelle clearance was blunted when compared with WT iNeurons (Extended Data Fig. 6d and Supplementary Table 7). In contrast, PKO iNeurons treated with Torin1 demonstrated a defect in the clearance of ER proteins (similar to ATG12−/−), whereas other organelles were largely unaffected (Extended Data Fig. 6d and Supplementary Table 7), consistent with selective roles for ER-phagy receptors. The ubiquitin-binding autophagy receptor CALCOCO1 has been reported to function as a soluble receptor for both Golgi and ER turnover in response to nutrient stress38,39, although a general function in ER- or Golgiphagy has been questioned36. While CALCOCO1 accumulated in ATG12−/− iNeurons during differentiation (Fig. 1c), iNeurons lacking CALCOCO1 displayed no global accumulation of ER or Golgi proteomes, unlike ATG12−/− iNeurons examined in parallel (Extended Data Fig. 6e–i and Supplementary Table 8). Thus, CALCOCO1 alone is not necessary for ER or Golgi maintenance in this system.
Quantitative modelling of ER proteome remodelling via ER-phagy
The behaviour of the ER proteome in single and combinatorial ER-phagy mutant iNeurons, with a range of altered protein abundances occurring across the ER proteome (Fig. 7a,b and Extended Data Fig. 7a,b), suggests both redundancy and selectivity for client turnover by receptors. To further probe this underlying specificity, we employed a linear model that measures the sequential effect of (1) FAM134A/C, (2) FAM134B, (3) TEX264 and (4) CCPG1 deletion. The model measures the positive or negative log2FC values, comparing each step, and assigns these changes with positive or negative β coefficients: (1) βWT→DKO; (2) βDKO→TKO, (3) βTKO→QKO and (4) βQKO→PKO (Fig. 7d, Extended Data Fig. 8a,b and Methods). The behaviour of FAM134A is an example of the applicability of the model (Fig. 7e): βWT→DKO was strongly negative (−2.5) and significant (indicated by the asterisk), consistent with its deletion in the DKO mutant compared to WT, but β coefficient values in subsequent deletions was near zero and not significant, as expected, because FAM134A remains deleted and therefore remains at the same abundance throughout the remainder of the allelic series.
Global analysis revealed an increase in the mean βWT→DKO coefficients for the ER proteome (0.21), which was primarily reflected in alterations in the abundance of ER-membrane and ER-lumen proteins (Fig. 7f). βDKO→TKO and βTKO→QKO coefficients reflecting the further deletion of FAM134B and TEX264, respectively, are near zero for the ER proteome as a whole and for specific ER subregions (Fig. 7f and Extended Data Fig. 8a), suggesting modest or no contributions to ER turnover in this context. In contrast, the mean βQKO→PKO coefficient resulted in an increase (0.15) for a cohort of ER lumenal proteins (Fig. 7f and Extended Data Fig. 8a), indicating that CCPG1 and FAM134A/C independently control the abundance of a set of lumenal proteins based on either the magnitude of abundance change or protein identity, as explored further in the following. The effect of CCPG1 on lumenal ER protein abundance is further demonstrated by organelle point plots comparing βTKO→QKO and βQKO→PKO, with significant displacement of ER lumen off the diagonal (Extended Data Fig. 8a). We next compared the organelle proteome abundance changes that occur when an individual deletion is made from the WT background to the organelle proteome abundance changes that occur when the same deletion is added to the sensitized background reflected by the β value for that deletion in the combinatorial deletion series (Extended Data Fig. 8c). The effect on the ER of single deletion of CCPG1 or of deletion of CCPG1 in the QKO to create the PKO suggests that CCPG1 can act alone as an ER-phagy receptor to clear luminal proteins during neuronal differentiation. However, the FAM134 family of receptors only yielded an increase in the ER network and different ER compartments when the FAM134 family was deleted in combination.
The finding that the combined loss of FAM134A and C leads to accumulation of a cohort of ER proteins and that the ER proteome was not substantially altered upon further deletion of FAM134B led us to ask whether FAM134A and B are functionally equivalent in this setting. We generated FAM134B/C−/− cells and performed multiplexed proteomics comparing FAM134C−/−, FAM134A/C−/− (DKO) and FAM134B/C−/− iNeurons (day 12) (Extended Data Fig. 8d and Supplementary Table 9). Global ER and ER-membrane protein abundance in particular also increased in FAM134B/C−/− iNeurons relative to FAM134C−/− iNeurons (Extended Data Fig. 8d). Taken together, this suggests that FAM134 copy number, rather than the identity of the specific isoform, underlies ER proteome remodelling in this context.
ER-phagy receptor substrate specificity
To directly examine the substrate selectivity of the ER-phagy receptors, we first explored the top 25 ranked proteins with positive β coefficients for both βWT→DKO and βQKO→PKO. When compared with all ER proteins, those with positive βWT→DKO coefficients were particularly enriched in ER-membrane proteins, whereas proteins with positive βQKO→PKO coefficients were enriched in lumenal proteins (Fig. 7g). Heatmaps revealing the identity of these top accumulators highlight the degree of change in the β coefficients, with significantly changing proteins marked with an asterisk (*adjusted P value < 0.05; positive or negative β coefficients, Fig. 8a). The extent of accumulation of these top-ranked proteins in PKO cells was similar to that seen with ATG12−/− iNeurons (Fig. 8a), indicating that the PKO mutant closely approximates the biochemical phenotype of ATG12 deficiency for ER turnover. Globally, we identified 84 membrane proteins with significantly (*adjusted P value < 0.05) positive or negative βWT→DKO coefficients, which were distributed across multiple functional categories and contained varying numbers of TM segments (Fig. 8b and Supplementary Table 3). Given that several of the ER-shaping proteins with RHDs are within this group of significant changers (Fig. 8b) and that ATG12 deficiency strongly affects ER-shaping proteins with RHDs (Fig. 1e), we examined this class of proteins further. In addition, we examined ER proteins that are specifically related to two neurological disorders, hereditary spastic paraplegia (HSP) and hereditary sensory and autonomic neuropathy (HSAN) (a subset of which are also ER curvature-shaping proteins that contain RHDs). Heatmaps of log2FC values for these specific ER proteins are provided in Extended Data Fig. 9a,b), and immunoblotting of selected proteins confirmed accumulation both in ATG12−/− and PKO iNeurons (Extended Data Fig. 9c). First, we found that a subset of ER-curvature proteins specifically increased in βWT→DKO, including RTN1-C (log2FC = 0.44; Fig. 8a–c and Extended Data Fig. 9c,d). Similarly, REEP5 accumulated—albeit to a lesser extent—in PKO iNeurons (Fig. 8b,c and Extended Data Fig. 9a,c), and Keima-REEP5 flux measurements revealed decreased flux in PKO cells, approaching that observed in ATG12−/− iNeurons (Fig. 8d). Second, a distinct set of RHD proteins (REEP1, REEP3 and REEP4) decrease in abundance, and display negative β coefficients for DKO (Fig. 8a,b,e and Extended Data Fig. 9a–c,e). REEP1 also further decreases upon deletion of TEX264, as indicated by a significant negative β coefficient and log2FC (Fig. 8e). Because members of the RHD protein family (for example, REEP1) are strongly upregulated during iNeuron differentiation (Fig. 1a–d and Extended Data Fig. 9f), alterations in abundance across the REEP family indicate distinct pathways for controlling ER shape remodelling for neurons, specifically via ER-phagy. Whereas the collective ER proteome did not increase with the single FAM134C deletion, abundance alterations for ER-shaping proteins specifically were observed with just the single deletion (Extended Data Fig. 9a), indicating that FAM134C probably contributes substantially to the differential regulation of shaping proteins during neurogenesis (Fig. 8c). Interestingly, ATG12−/− iNeurons display increases in abundance for all REEP proteins, indicating that a broad block to autophagy can mask otherwise distinct proteome remodelling events relevant to an individual ER-phagy receptor (Extended Data Fig. 9a–c,f).
To examine whether the loss of specific REEP family members is directly due to the loss of FAM134, we ectopically expressed FAM134C-GFP in either WT or DKO hESCs using a PiggyBac vector and converted the cells to iNeurons (day 12) (Extended Data Fig. 9g–i). Immunoblotting of the cell extracts revealed that the increase in TEX264 abundance and the decrease in REEP1 or REEP4 in DKO cells is reversed by the re-introduction of FAM134C-GFP (Extended Data Fig. 9g,i). Similarly, proteomics revealed that FAM134C-GFP expression in DKO iNeurons reversed the global accumulation of a cohort of ER proteins, in particular ER-membrane proteins (Extended Data Fig. 9h and Supplementary Table 10). Proteomics also validated rescue in the expression of REEP1/2/3; REEP4 was not detected in this specific experiment (Extended Data Fig. 9i).
The ER lumenal compartment is primarily responsible for folding and modification of secretory and membrane proteins, but proteins in this compartment have also been reported to undergo autophagic trafficking8,40,41. We identified two major patterns of ER lumenal protein abundance changes, reflected in the βWT→DKO and βQKO→PKO coefficients. In total, 25 ER lumen proteins (primarily lacking a TM) were stabilized in the DKO mutant, and ten of these were further stabilized in PKO mutants (Fig. 8b and Supplementary Table 3). In contrast, a distinct cohort of 16 ER lumen proteins was stabilized specifically in the PKO mutant, with no significant effect observed with DKO, TKO or QKO mutants (for example, P4HA1 and P4HA2) (Fig. 8a,b, Extended Data Fig. 10a,b and Supplementary Table 3), and the log2FC for these lumenal proteins was also stabilized in ATG12−/− iNeurons (Extended Data Fig. 10b). These findings suggest both redundant and specific lumenal cargo for FAM134A/C and CCPG1 receptors. We also found it compelling that deletion of CCPG1 alone or in the context of a TEX264−/−/CCPG1−/− double mutant resulted in increased abundance of a subset of lumenal proteins with significant similarities to that seen with the PKO mutant (Extended Data Figs. 8c and 10b,c and Supplementary Table 11).
Intriguingly, the single TM segment proteins VAPA and VAPB, which mediate contact site interactions between ER and a number of other organelles, including mitochondria, via an interaction with VPS13 and other lipid transfer proteins42, have a positive β coefficient in DKO and/or PKO mutants, indicating that VAPs undergo multiple modes of ER-phagic turnover (Fig. 8a,b,f and Extended Data Fig. 10d). An increase in VAPA abundance was also observed by immunoblotting in both ATG12−/− and PKO iNeurons (Extended Data Fig. 9c). To directly examine the hypothesis that VAPA is an ER-phagy client, we created a Keima-VAPA reporter construct that was expressed via PiggyBac in WT, ATG12−/− and PKO iNeurons. We found that Keima-VAPA autophagic flux was reduced in PKO iNeurons to an extent similar to that seen with ATG12−/− iNeurons, consistent with the idea that VAPA is a substrate for ER-phagy (Fig. 8g). VAPA abundance was also increased in ATG5−/− cerebellar granule neurons in culture22. In parallel, β-coefficient correlation plots for organelles revealed selective accumulation of mitochondria as a result of CCPG1 deletion (Extended Data Figs. 5c and 8a–c). These findings encourage further study into how ER-phagy mechanisms are regulating the ER architecture to facilitate functions like maintaining robust yet dynamic contact sites with other organelles.
Discussion
Previous studies have indicated that loss of autophagy pathways in neurons from mice or in iNeurons from hESCs leads to increased accumulation of ER proteins22,25, but the extent to which this reflects non-specific macroautophagy or selective ER-phagy was unknown. The use of a genetically tractable iNeuron system, which displays a dramatic accumulation of axonal ER in the absence of a functional autophagy system25, has allowed us to examine roles for multiple ER-phagy receptors during ER remodelling associated with neurogenesis.
We found that FAM134C and TEX264 are mobilized into LC3B-positive vesicles that traffic in axons. During nutrient stress, FAM134 and TEX264 are concentrated into the same ER structures that are captured during ER-phagy, whereas CCPG1 forms distinct domains9. Current models indicate that ER serves as a source of lipids for phagophore formation, but that ER-membrane proteins themselves are not incorporated into autophagosomal membranes23,24. Thus, we conclude that FAM134C- and TEX264-positive puncta reflect ER-phagy rather than the process of autophagosome biogenesis as previously observed in distal axons34. Importantly, we observed numerous autophagosomes in axons via cryo-ET, some of which contain ER membranes and TEX264-GFP in correlative imaging. Tomogram reconstruction revealed the presence of membranes consistent with tubular ER (Fig. 5). Mutation of FAM134A and C or FAM134B and C was sufficient to produce a global increase in the ER proteome, with the TM ER proteome featured prominently among the most stabilized proteins. In contrast, deleting CCPG1 in different allelic backgrounds revealed CCPG1’s primary role in clearing lumenal proteins. Unlike FAM134 family members and TEX264, CCPG1 contains a lumenal domain that has been suggested to associate with lumenal autophagy substrates8,40,43. Our proteomic analysis validates previously reported CCPG1 cargo (for example, P3H4)40 and provides additional candidates for further analysis. Unlike ER-phagy in response to nutrient stress9,10, it does not appear that loss of TEX264 alone affects ER network clearance during neurogenesis, and our results suggest that TEX264 ER-phagic clearance is dependent on the FAM134 ER-phagy receptor family in this context.
FAM134 proteins are thought to cluster into highly curved membranes during an early step in ER-phagy initiation, thereby promoting ER-membrane budding and scission of ER membrane into autophagosomes15,21. Other RHD-containing proteins, including REEP5 and ARL6P1/521,44, can associate with FAM134C. Although the majority of REEP proteins and several RTN proteins accumulated in ATG12−/− iNeurons, cells lacking FAM134A/C accumulate REEP5 and RTN1 but display loss of REEP1–4. REEP1–4 protein abundance was rescued upon expression of FAM134C-GFP in FAM134A/C−/− cells. One possible explanation for this result is that FAM134 proteins facilitate REEP1–4 trafficking or stability. Unlike REEP5/6, which contain four reticulon helices within the outer leaflet of the ER membrane, REEP1–4 contain only three such helices and therefore may have distinct functional properties. REEP1–4 orthologues bind to highly curved membranes, including small vesicles, in contrast to REEP5/645,46. Future studies are required to understand the distinct properties of REEP proteins observed here and to understand any role of receptor phosphorylation8,47,48 in neuronal ER-phagy. This Article provides a versatile resource for further interrogating how ER remodelling is optimized for various cell states via selective ER-phagy.
Methods
Research within this publication complies with relevant ethical regulations. Commercially sourced H9 hESCs (WiCell) were exempted by Harvard University Embryonic Stem Cell Research Oversight Committee under approval no. E00051 as human subjects research due to patient de-identification.
Protocols associated with this work can be found on protocols.io at https://doi.org/10.17504/protocols.io.81wgbx13nlpk/v3.
Reagents
The following chemicals, peptides and recombinant proteins were used: DAPI (Thermo Fisher Scientific, D1306); TMTpro 16plex Label Reagent Set (Thermo Fisher Scientific, A44520); Q5 Hot Start High-Fidelity DNA Polymerase (New England BioLabs, M0493); Gateway LR Clonase II Enzyme Mix (Thermo Fisher Scientific, 11791020); NEBuilder HiFi DNA Assembly Master Mix (E2621s); MiSeq Reagent Nano Kit v2 (300 cycles; Illumina, MS-103-1001); bafilomycin A1 (Cayman Chemical, 88899-55-2); Sar405 selective ATP-competitive inhibitor of Vps34 (Apexbio, A8883); DAPI (4′,6-diamidino-2-phenylindole, dihydrochloride; Thermo Fisher Scientific, D1306); 16% paraformaldehyde (EM grade; Electron Microscopy Science, 15710), PhosSTOP (Sigma-Aldrich, T10282); protease inhibitor cocktail (Roche, 4906845001); TCEP (Gold Biotechnology), formic acid (Sigma-Aldrich; 94318); trypsin (Promega, V511C); Lys-C (Wako Chemicals, 129-02541); urea (Sigma, U5378); EPPS (Sigma-Aldrich, E9502); 2-chloroacetamide (Sigma-Aldrich, C0267); Trypan Blue stain (Thermo Fisher Scientific, Wako Chemicals, 129-02541w); urea (Sigma, U5378); EPPS (Sigma-Aldrich, E9502); 2-chloroacetamide (Sigma-Aldrich, C0267); Empore SPE Disks C18 3M (Sigma-Aldrich, 66883-U); GeneArt Precision gRNA synthesis kit (Thermo Fisher Scientific, A29377); 12-well glass-bottom plate with high performance #1.5 cover glass (Cellvis, P12-1.5H-N); Nunc Cell-Culture Nunclon Delta treated 6-well plate (Thermo Fisher Scientific, 140685); Nunc Cell-Culture Nunclon Delta treated 12-well plate (Thermo Fisher Scientific, 150628); 100 × 21-mm dish, Nunclon Delta (Thermo Fisher Scientific, 172931); Corning Matrigel Matrix, growth factor reduced (Corning, 354230); DMEM/F12 (Thermo Fisher Scientific, 11330057); neurobasal (Thermo Fisher Scientific, 21103049); non-essential amino acids (NEAAs, Life Technologies, 11140050); GlutaMAX (Life Technologies, 35050061); N-2 supplement (Thermo Fisher Scientific, 17502048); neurotrophin-3 (NT3) (Peprotech, 450-03); brain-derived neurotrophic factor (BDNF; Peprotech, 450-02); B27 (Thermo Fisher Scientific, 17504001); Y27632 dihydrochloride (ROCK inhibitor; PeproTech, 1293823); Cultrex 3D culture matrix laminin I (R&D Systems, 3446-005-01); accutase (StemCell Technologies, 7920); FGF3 (in-house, N/A); human insulin (Sigma-Aldrich, I9278-5ML); transforming growth factor-β (PeproTech, 100-21C); holo-transferrin human (Sigma-Aldrich, T0665); sodium bicarbonate (Sigma-Aldrich, S5761-500G); sodium selenite (Sigma-Aldrich, S5261-10G); doxycycline (Sigma-Aldrich, D9891); recombinant SpCas949; hygromycin B (Thermo Fisher Scientific, 10687010); UltraPure 0.5 M EDTA, pH 8.0 (Thermo Fisher Scientific, 15575020); GlutaMAX (Thermo Fisher Scientific, 35050061); Dulbecco’s MEM (DMEM), high-glucose pyruvate (GIBCO/Invitrogen, 11995); Lipofectamine 3000 (Invitrogen, L3000008); Click-iT Plus TUNEL assay (Invitrogen, C10617, with Alexa Fluor 488); tunicamycin (Cell Signaling, 12819S); RNAeasy Qiagen kit (Qiagen, 74104); Qiashredder columns (Qiagen, 79654); DNAseI (Thermo, EN0521); oligo dT20 primers (Invitrogen, 79654); dNTPs (NEB, N0447L).
Plasmids
Plasmids constructed for and used in this manuscript will be available at Addgene upon final publication. These include pAC150-Keima-RAMP4 (this Article, Addgene 201929, RRID:Addgene_201929); pAC150-Keima-VAPA (this Article, Addgene 212096, RRID:Addgene_212096); pAC150-Keima-REEP5 (this Article, Addgene 201928, RRID:Addgene_201928); pAC150-FAM134C-GFP (this Article, Addgene 201932, RRID:Addgene_201932); pAC150- TEX264- GFP (this Article, Addgene 201931, RRID:Addgene_201931); pAC150-TEX264(deltaLIR, F273A)-GFP (this Article, Addgene 201930, RRID:Addgene_201930), pHAGE-FAM134C-GFP (this Article, Addgene 201927, RRID:Addgene_201927); pHAGE-TEX264-GFP (Addgene 201925, RRID:Addgene_201925)9; pHAGE-TEX264(deltaLIR,F273A)-GFP (Addgene 201926, RRID:Addgene_201926)9; pHAGEmCherry-LC3B (Addgene 201924, RRID:Addgene_201924)9.
Cell culture
hESCs (H9, WiCell Institute, WA9, RRID CVCL_9773) or iPSCs (KOLF2.1, Jackson Labs CVCL_D1J6) were cultured in E8 medium on Matrigel-coated plates, as described in ref. 25. Cells were split when they reached 80% confluency (every 2–4 days) using 0.5 mM EDTA in 1× Dulbecco’s Phosphate-Buffered Saline (Thermo Fisher Scientific).
Neural differentiation of AAVS1-TRE3G-NGN2 pluripotent stem cells
TRE3G-NGN2 was integrated into the adeno-associated virus integration site (AAVS) of the hESCs and iPSCs as previously described50. To start differentiation to iNeurons from stem cells (day 0), cells were plated at 2 × 105 cells ml−1 onto Matrigel-coated plates into ND1 medium (DMEM/F12, 1X N2 (Thermo Fisher Scientific), human BDNF (10 ng ml−1; PeproTech), human neurotrophin-3 (NT3, 10 ng ml−1; PeproTech), 1X NEAA, human laminin (0.2 μg ml−1) and doxycycline (2 mg ml−1) also containing Y27632 (ROCK inhibitor, 10 mM). The medium was replaced with ND1 without Y27632 the next day. The following day, the medium was replaced with ND2 (neurobasal medium, 1X B27, 1X GlutaMAX, BDNF (10 ng ml−1), NT3 (10 ng ml−1) and doxycycline at 2 mg ml−1. On days 4 and 6, 50% of the medium was changed with fresh ND2. On any day in the day 4–7 range, cells were replated at 4 × 105 cells well−1 in ND2 medium with Y27632. The medium was replaced the next day with fresh ND2 (without Y27632). Every other day, 50% of the medium was changed with ND2. At day 9 and onwards, doxycycline was removed from the ND2 mixture. iNeurons were fed every other day with 50% medium change until the experimental day (day 12 of differentiation, unless otherwise noted).
Molecular cloning
Plasmids were made using either Gateway technology (Thermo Fisher Scientific) or Gibson assembly (New England Biolabs) in the pHAGE backbone (for lentivirus transduction) or in the pAC150 piggyBac backbone (for stable hESC generation). Entry clones from the human ORFeome collection, version 8, were obtained and cloned via in vitro recombination between each entry clone which contains the gene of interest flanked by attL sites and to various destination vectors containing attR sites (LR cloning).
Viral transduction of iNeurons
Lentiviral vectors were packaged in the HEK293T cell line (ATCC, CRL-1573, RRID: CVCL_0045) by co-transfection of pPAX2 (Addgene 12259, RRID:Addgene_12259), pMD2 (Addgene 12260, RRID:Addgene_12260) and the vector of interest in a 4:2:1 ratio using Lipofectamine 3000. One day after transfection, the medium was changed to ND2 (no doxycycline), then, the following day, virus containing supernatant was collected, filtered through a 0.22-μm syringe filter and frozen at −80 °C. hESCs or iPSCs were differentiated to neurons as described above. At day 11 (two days after doxycycline removal) the iNeurons were transduced. iNeurons were imaged one day after transduction or on any following day (the experimental day is noted in each figure).
Stable hESC population generation
The piggyBac plasmids freshly Maxiprepped at high concentrations were electroporated into hESCs using the 10-μl Neon Thermo Fisher kit and Thermo Fisher Neon Electroporator, then 1.5 μg of pAC150 piggyBac vectors for ER proteins (Keima-RAMP4, TEX264-GFP, FAM134C-GFP and 1 μg of pCMV-hyPBase hyperactive piggyBac vector). Next, 2 × 105 cells in 10 μl of buffer R were used for each electroporation. Program 13 was used from the optimization tab for the electroporation parameters (voltage, 1,100; pulse width, 20; pulse number, 2). We plated the electroporated ESCs into Matrigel-coated plates containing E8 with Y27632 (ROCK inhibitor, 10 mM) and the cells were placed in a low-O2 incubator for two to four days. After four days with regular E8 medium changes daily (or when the cells reached 80% confluency), the cells were split into selection medium (E8 with Y27632 and 50 μg ml−1 hygromycin B). The cells were grown in the selection medium for seven to ten days until there was no longer any cell death, then the cells were further selected to obtain a fluorophore-positive population via flow cytometry with a Sony Biotechnology (SH800S) cell sorter.
Gene editing
Gene editing in the hESCs was performed as in ref. 51. Guide RNAs (sgRNAs) were generated using the GeneArt Precision gRNA synthesis kit (Thermo Fisher Scientific), then 0.6 μg of sgRNA was incubated with 3 μg of SpCas9 protein for 10 min at room temperature and electroporated into 2 × 105 H9 cells using a Neon transfection system (Thermo Fisher Scientific). The cells were placed in a low-O2 incubator and allowed to recover for 24–72 h, then they were single-cell-sorted into 96-well plates with the Sony Biotechnology (SH800S) cell sorter and grown up for 7–12 days. Individual clones were verified for out-of-frame deletions by DNA-sequencing with an Illumina MiSeq system, and protein deletion was verified by immunoblotting. The sgRNA target sequences were as follows: CCPG1 sgRNA TTCTAACTTAGGTGGCTCAA, TEX264 sgRNA CATGTCGGACCTGCTACTAC, FAM134A sgRNA TAATACGACTCACTATAG, FAM134B sgRNA GTCTGACACAGACGTCTCAG, FAM134C sgRNA AACTTGAGCTGTCAGACCAACA and sgRNA CALCOCO1 TGTGGTCTTCCGTGCCTGAAAGTA. The cell lines reported here are available upon request, but transfer requires that the recipient have a licence for H9 ESCs from WiCell.
Antibodies
The following antibodies were used: ATG5 rabbit monoclonal (D5F5U) antibody (Cell Signaling Technology 12994S, lot 5, western blot (WB) 1:1,000, RRID: AB_2630393); FAM134B rabbit polyclonal antibody (Proteintech 21537-1-AP, lot 00100765, WB 1:1,000 RRID: AB_2878879); FAM134C rabbit polyclonal antibody (Sigma-Aldrich HPA016492, lot R06641, WB 1:1,000, RRID: AB_1853027); CCPG1 rabbit monoclonal (E3C5G) antibody (Cell Signaling Technology 80158, lot 1, WB 1:1,000, RRID: AB_2935809); TEX264 rabbit polyclonal antibody (Sigma-Aldrich HPA017739, lot 000012723, WB 1:1,000, RRID :AB_1857910); REEP1 rabbit polyclonal antibody (Sigma-Aldrich HPA058061, lot R81573, WB 1:1,000, RRID: AB_2683591); REEP4 rabbit polyclonal antibody (Sigma-Aldrich HPA042683, lot R39936, WB 1:1,000, RRID: AB_2571730); REEP5 rabbit polyclonal antibody (Proteintech 14643-1-AP, lot 00050540, WB 1:1,000, RRID: AB_2178440); RTN3 mouse monoclonal (F-6) antibody (Santa Cruz sc-374599, lot 10922, WB 1:1,000, RRID: AB_10986405); CKAP4/p63 sheep polyclonal antibody (RD Biosciences AF7355, lot CGDGG012105B, WB 1:1,000, RRID: AB_10972125); CKAP4 rabbit polyclonal antibody (Proteintech 16686-1-AP, lot 0052093, WB 1:1,000, RRID: AB_2276275); hFAB rhodamine anti-tubulin antibody (BioRad 12004166, lot 64512247, WB 1:10,000, RRID: AB_2884950); HSP90 mouse monoclonal (4F10) antibody (Santa Cruz sc-69703, lot J2721, WB 1:10,000, RRID: AB_2121191); GAPDH XP rabbit monoclonal (D16H11) antibody (Cell Signaling Technology 5174, lot 8, WB 1:1,000, RRID: AB_10622025); CREB-2/ATF4 mouse monoclonal (B-3) antibody (Santa Cruz, sc-390063, lot J2021, WB 1:1,000, RRID: AB_2810998); VAPA rabbit monoclonal (EPR13589(B)) antibody (Abcam ab181067, lot GR164232-2, WB 1:1,000, RRID: AB_3073850); RTN1 (isoform RTN1-C) rabbit polyclonal antibody (Proteintech 15048-1-AP, lot 00043268, WB 1:1,000, RRID: AB_2185981); goat anti-rabbit immunoglobulin-G (IgG) horse radish peroxidase (HRP) conjugate (BioRad 1706515, lot 64559210, WB 1:3,000, RRID: AB_11125142); goat anti-mouse IgG HRP conjugate (BioRad 1706516, lot 64526160; WB 1:3,000, RRID: AB_11125547); neurofilament heavy polypeptide mouse monoclonal (NF-01) antibody (Abcam ab7795, lot GR3448163-1, IF 1:300, RRID: AB_306084); MAP2 guinea pig polyclonal antibody (Synaptic Systems 188004, lot 6-49, IF 1:300, RRID: AB_2138181); Nogo-A (RTN4) mouse monoclonal (C-4) antibody (Santa Cruz sc-271878, lot D2420, IF 1:300, RRID: AB_10709573); calnexin rabbit polyclonal antibody (Proteintech 10427-2-AP, lot 00094417, IF 1:300, RRID: AB_2069033); goat anti-mouse Alexa488 (Thermo Fisher Scientific A-11001, lot 2379467, IF 1:300, RRID: AB_2534069); goat anti-chicken Alexa488 (Thermo Fisher Scientific A11039, lot 218068, IF 1:300, RRID: AB_2534096); goat anti-rabbit Alexa568 (Thermo Fisher Scientific A-11011, lot 2500544, IF 1:300, RRID: AB_143157); goat anti-rabbit Alexa647 (Thermo Fisher Scientific A27040, lot 2659317, IF 1:300, RRID: AB_2536101); goat anti-guinea pig Alexa488 (Thermo Fisher Scientific A-11073, lot 38320A, IF 1:300, RRID: AB_2534117); goat anti-guinea pig Alexa647 (Thermo Fisher Scientific A-21450, lot 2446026, IF 1:300, RRID: AB_141882).
Western blotting
Cell pellets were resuspended in 8 M urea buffer (8 M urea, 150 mM Tris pH, 150 mM NaCl) supplemented with protease and phosphatase inhibitor tablets and then sonicated twice, 10 s each, on ice. The lysates were clarified via centrifugation at 20,000g for 10 min at 4 °C. bicinchoninic acid (BCA) assays were performed on clarified lysates, and normalized lysate amounts were boiled in 1X SDS containing Laemmeli buffer. Lysates were run on 4–20% Tris glycine gels (BioRad) and transferred via wet transfer onto polyvinylidene difluoride membranes for immunoblotting with the indicated antibodies. Images of blots were acquired using enhanced chemiluminescence or using the rhodamine channel on a BioRad ChemiDoc imager, and the images were quantified and converted to jpeg for publication using BioRad Image Lab Software v5.2.5 RRID:SCR_014210.
Flow cytometry
hESCs that were converting to neurons were grown in six-well plates and treated with various drugs for the indicated time points, then cell pellets were collected at the indicated day of neuronal differentiation. These were resuspended in FACS buffer (1X PBS, 2% FBS). At least 10,000 cells were analysed on an Attune NxT flow cytometer (Thermo Fisher Scientific, cat. no. A28993). The neutral Keima signal was measured at an excitation of 445 nm and emission of 603 nm with 48-nm bandpass, and the acidic Keima signal was measured at an excitation of 561 nm and emission of 620 nm with 15-nm bandpass. The resulting cell-population Keima ratio was analysed as previously described52. In brief, FCS files were exported into FlowJo (Version 10.5.2, RRID:SCR_008520, https://www.flowjo.com/solutions/flowjo), where the cells were gated for live cells, single cells and Keima-positive cells. The 561 nm (acidic) to 445 nm (neutral) excitation ratio was calculated by dividing the mean values of the 561-nm excited cells by the mean values of the 445-nm excited cells.
Imaging
Cells were plated onto 6-well, 12-well or 24-well glass-bottom plates with high-performance #1.5 cover glass (CellVis). Live cells were imaged at 37 °C at 5% CO2. For the immunofluorescence experiments, cells were fixed at room temperature with 4% paraformaldehyde in PBS, solubilized in 0.1% Triton-X in PBS and blocked with 1% BSA/0.1% Triton-X in PBS. Cell were then immunostained with anti-primary antibodies used at 1:500 and then Alexa Fluor-conjugated antibodies (Thermo Fisher) used at 1:300. The primary and secondary antibodies used in this study are identified in the Antibodies section above and described for each experiment detailed in the following. Fixed cell images were captured at room temperature. Cells were imaged using a Yokogawa CSU-X1 spinning disk confocal unit on a Nikon Ti-E inverted microscope at the Nikon Imaging Center in Harvard Medical School. The Nikon Perfect Focus System was used to maintain cell focus over time. The microscope was equipped with a Nikon Plan Apo ×40/1.30 NA or ×100/1.40 NA objective lens and 445-nm (75 mW), 488-nm (100 mW), 561-nm (100 mW) and 642-nm (100 mW) laser lines controlled by Acousto-Optic Tunable Filter system. All images were collected with a Hamamatsu ORCA-Fusion BT sCMOS camera (6.45-µm2 photodiode) with Nikon Elements (version AR, RRID:SCR_014329) image acquisition software.
Analysis of ER structures in axons
hESC-derived iNeurons were imaged at the indicated day in neuronal differentiation. Cells were fixed and stained as described above with α-calnexin to detect ER, α-MAP2 to detect dendrites, α-NEFH to mark axons, and DAPI to detect nuclei. The z stacks were acquired with the parameters stated above in the Imaging section, and the z series are displayed as maximum z projections, with the brightness and contrast adjusted for each image equally and then converted to rgb for publication using Fiji software (Version 2.0.0, RRID:SCR_014329, http://fiji.sc). Fiji software was also used to split the z projections into individual channels for downstream image analysis in CellProfiler Image Analysis Software (Version 4.2.5, RRID:SCR_007358, http://cellprofiler.org)53. Each field of view for all genetic backgrounds was thresholded in the same way with a consistent pipeline. The ‘identify primary objects’ tool was used to find nuclei, axons, dendrites and ER structures. The α-NEFH-positive axon object regions were used to create an axon mask, and ER structures within this mask were counted. The area of each ER structure was also measured. The number of ER axonal structures was then compared to the number of detected nuclei.
Analysis of cell nuclei using size
We assayed whether nuclei were intact in the images used to assess the amount and size of ER structures in the axons, as described above in the Imaging section (α-calnexin to detect ER, α-MAP2 to detect dendrites, α-NEFH to mark axons, DAPI to detect nuclei, and with z projections already split into individual channels as detailed above for downstream image analysis in CellProfiler53). The DAPI channel images for all genetic backgrounds were thresholded in the same way with the following pipeline. Two different ‘identify primary objects’ modules were used to find and count nuclei structures. In one, only larger ‘intact’ nuclei were selected and counted (as was done previously for the analysis of ER structures in axons to determine ER structures per nuclei). In the second, smaller fragmented nuclei were included in the thresholding method. The ratio of intact to total DAPI-positive nuclei structures was calculated and reported for each condition.
Analysis of cell nuclei using TUNEL
As secondary confirmation that the intact nuclei that we were assaying were indeed healthy, we performed a Click-iT Plus TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labelling) assay (Invitrogen, C10617, Alexa Fluor 488), which detects DNA breaks formed when DNA fragmentation occurs at the end of apoptosis. We prepared four new differentiations of WT, ATG12 and PKO neurons (hESC-derived) at day 20 to perform this staining. In short, following the kit protocol, after fixing and permeabilizing the iNeurons as already described, we followed the kit directions to first perform a TdT reaction. In this reaction, the TdT enzyme takes EdUTP (a dUTP modified with a small, bio-orthogonal alkyne moiety) and incorporates it at the 3′-OH ends of fragmented DNA. Next, we performed the click reaction, a copper-catalysed covalent reaction occurring between the Alexa Fluor picolyl azide dye and an alkyne. Detection of the DNA break is based on the Alexa Fluor signal at that site. After performing this Click-iT Plus TUNEL reaction, we next stained with DAPI to label all DNA structures (this labels both intact and fragmented DNA). The z stacks were acquired with the parameters stated above. The z series are displayed as maximum z projections and brightness, and the contrast was adjusted for each image equally and then converted to rgb for publication using Fiji software. Fiji software was also used to split the z projections into individual channels for downstream image analysis in CellProfiler53. For the TUNEL channel images, images from all genetic backgrounds were thresholded in the same way using an ‘identify primary objects’ module to find and count all damaged DNA structures, including larger and smaller structures. For the DAPI channel images, two different ‘identify primary objects’ modules were used to find and count the DAPI structures. In one, only larger ‘intact’ DAPI-positive nuclei were selected. In the second, smaller fragmented DAPI-positive nuclei were included in the thresholding method. To calculate the total nuclei number, the number of damaged TUNEL-positive DNA structures was added to the number of intact DAPI nuclei. In the final analysis, the ratio of intact DAPI-positive nuclei structures to total nuclei (damaged TUNEL-positive nuclei plus intact) was calculated and reported for each condition.
Visualizing Keima-ER in neuronal differentiation
Live cells (hESC-derived) stably expressing Keima-RAMP4 (localizes to all ER) or Keima-REEP5 (localizes to ER tubules specifically) were imaged at the indicated day in neuronal differentiation. Pairs of images for ratiometric imaging of Keima-RAMP4 fluorescence were collected sequentially using 100-mW 442-nm (neutral Keima excitation) and 100-mW 561-nm (acidic Keima excitation) solid-state lasers, and the emission was collected with a 620/60-nm filter (Chroma Technologies). The z stacks were acquired with a Nikon Plan Apo ×40/1.45-NA oil-objective lens. The z series are displayed as maximum z projections, and the brightness and contrast were adjusted for each image equally and then converted to rgb for publication using Fiji software. Fiji software was also used to split the z projections into individual channels. For each channel, complementary line scans, 30 μm long and 1.7 μm wide, were drawn in either the soma or projection of the iNeurons. The 561-nm or 442-nm grey values along these lines were measured using ‘plot profile’ in Fiji. The 561/442 ratio of these values at each complementary point along the line was calculated and plotted in Microsoft Excel (Version 16.81, RRID:SCR_016137, https://www.microsoft.com/en-gb/).
Characterizing the spatial and temporal properties of ER-phagy receptors
hESCs with WT or ATG12−/− genetic background stably expressing WT or mutant TEX264-GFP or FAM134C-GFP were converted to neurons and treated with various drugs for the indicated time points, and imaged at the indicated day in neuronal differentiation. The z stacks were acquired with the parameters stated above. The z series are displayed as maximum z projections and brightness and contrast were adjusted for each image equally and then converted to rgb for publication using Fiji software.
For day-4 cells (untreated or treated with the indicated drugs), the number of GFP puncta per cell was quantified using CellProfiler. Each field of view for all genetic backgrounds and drug treatments was thresholded in the same way with a consistent pipeline. Using the ER-phagy receptor (488 nm excitation, GFP channel) max z-projection image, the ‘identify primary objects’ tool was used to detect cells (the receptor labels the whole ER membrane, which can be used to identify cells) and to detect puncta (small bright circles found within the ER membrane). The puncta were linked to each cell, and the puncta per cell number were exported.
Autophagosome (LC3B) and ER-phagy receptor (TEX264 or FAM134C) co-labelling was achieved by transducing with mCh-LC3B and receptor-GFP lentivirus. Day-30 neurons were imaged live for 30 min with an image acquired every 30 s. Fiji was used to track GFP- and mCh-positive puncta. Lines between each frame were used to measure the distance travelled by the puncta from frame to frame. The forward direction is reported as a positive value in micrometres and the backward direction as a negative value. Events in neurons from three independent differentiations were captured. The events were binned based on their speed of movement in units of micrometres per second. The percentage of events at each speed was plotted as using GraphPad Prism (9.5.0).
After live-cell imaging at day 30, the ER-phagy receptor and mch-LC3B-positive transduced neurons were fixed as described above. The iNeurons were immunostained with α-MAP2 to detect dendrites and α-NEFH to mark axons. The z stacks were acquired with the parameters stated above. The z series are displayed as maximum z projections, and the brightness and contrast were adjusted for each image equally and then converted to rgb for publication using Fiji software.
RNA extraction, RT–PCR, DNA gel electrophoresis
At day 12, iNeurons (hESC-derived) of each genotype were left untreated or treated with tunicamycin. After 4 h, all the cells were scraped off the dishes, pelleted and washed three times with PBS. The number of cells was determined and the pellets were snap-frozen in liquid nitrogen and stored at −80 °C for a few days before use. The cell pellets were thawed and resuspended in freshly prepared RNeasy Lysis Buffer (350 µl per sample for 1 × 106 cells) from the RNAeasy Qiagen kit (Qiagen, 74104). Dnase1 digestion buffer was then added, and the cells were lysed by passage through a Qiashredder column (Qiagen, 79654). One volume of 70% ethanol was added to the lysate, and the lysate–EtOH solution was transferred to an RNAeasy spin column. The following spins including on column DNAseI (Thermo Fisher Scientific, EN0521) digestion, buffer washes and RNA elution, were performed following the RNAeasy Qiagen kit directions. The concentration of final extracted RNA for each condition was measured using a NanoDrop spectrophotometer. Reverse transcription reactions for each condition (using the same amount of starting micrograms of RNA, 0.5 µg, in each reaction) were performed with Superscript III reverse transcriptase master mix (Invitrogen, 18080-051) using oligo dT20 primers (Invitrogen, 79654) and dNTPs (NEB, N0447L) to create complementary DNA (cDNA). With the cDNA, PCR reactions were performed to amplify cDNA from GAPDH mRNA (forward 5′-GGATGATGTTCTGGAGAGCC-3′; reverse 5′-CATCACCATCTTCCAGGAGC-3′) or to amplify cDNA from unspliced XBP1 mRNA or spliced XBP1 mRNA (forward 5′-CCTTGTAGTTGAGAACCAGG-3′; reverse 5′-GGGGCTTGGTATATATGTGG-3′) (as performed in refs. 54,55). The PCR products were electrophoresed on a 2.5% agarose gel. The size difference between the spliced and unspliced XBP1 was 26 nucleotides.
Transmission electron microscopy
Cell preparation
iNeurons were grown on Aclar plastic discs in 12-well plates coated with Matrigel. At day 20, the iNeurons were fixed with 2.5% glutaraldehyde, 1.25% paraformaldehyde and 0.03% picric acid in 0.1 M sodium cacodylate buffer (pH 7.4). A 2× solution was diluted 1:1 with the cell medium in the dish. Cells were fixed at room temperature for 1 h.
Epon embedding
The following steps were performed by the Harvard Medical School Electron Microscopy Core: cells were washed in 0.1 M sodium cacodylate buffer (pH 7.4), post-fixed for 30 min in 1% osmium tetroxide (OsO4)/1.5% potassium ferrocyanide (KFeCN6), washed twice in water and once in maleate buffer and incubated in 1% uranyl acetate in maleate buffer for 30 min followed by two washes in water and subsequent dehydration in grades of alcohol (5 min each; 50%, 70%, 95%, 2 × 100%). The samples were subsequently embedded in TAAB Epon (TAAB Laboratories Equipment, https://taab.co.uk) and polymerized at 60 °C for 48 h. Note on embedding—a drop of Epon was placed onto a clean piece of Aclar, then the coverslip was removed from 100% EtOH with a pair of fine-tipped forceps. Excess EtOH was removed by quickly blotting the side of the coverslip onto filter paper (to make sure the cells do not dry out) and the coverslips were placed (cell side down) onto the Epon drop. A small weight on top helped with keeping it flat. After polymerization, the Aclar was peeled off, a small area (~1 mm) of the flat embedded cells was cut out with a razor blade and remounted on an Epon block. Ultrathin sections (~80 nm) were cut on a Reichert Ultracut-S microtome, picked up onto copper grids stained with lead citrate and examined in a TecnaiG² Spirit BioTWIN and images recorded with an AMT 2k charge-coupled device camera. Regions close to the coverslip were specifically targeted to capture neuronal processes, not somata.
Cryo-electron tomography
Cryo-ET sample preparation and freezing
AAVS-TREG3-NGN2 non-embryonic and internationally accepted iPSCs were differentiated to iNeurons (KOLF2.1) and cultured on EM grids as described in detail in the following protocol: https://www.protocols.io/view/neural-differentiation-on-em-grids-ineurons-sample-5jyl8jz36g2w/v2. In this particular case, a 200-mesh gold grid with silicon dioxide R2/1 film (Quantifoil) was coated with Matrigel as reported in the protocol. The iPSC-derived iNeurons on the grid were transduced at day 12 with lentiviruses carrying mCherry-LC3B and TEX264-GFP. In the following days, the medium was gradually and completely exchanged with ND2 without phenol red (prepared using phenol red-free Neurobasal; Thermo Fisher, Gibco 12348017). The iNeurons were plunge frozen on DIV 18 using a Vitrobot Mark IV unit (Thermo Fisher Scientific) with application of 4 μl of phenol red-free ND2 medium and with the following settings: room temperature, humidifier 70%, Blot-Force 8, Blot-Time 9 s.
Cryo-fluorescence data acquisition and processing
Fluorescence stacks of the grid squares of interest were acquired before tilt-series acquisition on an SP8 cryo-confocal laser scanning microscope equipped with a cryo stage and a ×50/0.9-NA objective (Leica). Stacks were acquired sequentially in the red (excitation, 552 nm/emission, 598–625 nm) and green (excitation, 488 nm/emission, 498–525 nm) channels using hybrid detectors, with an x/y pixel size of 60 nm and a z step size of 400 nm. Transmitted light data were collected simultaneously to visualize the positions of the support film holes for 2D registration and correlation. Fluorescence data were deconvolved with Huygens (SVI) (Version 21.10.0p0, RRID:SCR_014237, https://svi.nl/HuygensSoftware) using a theoretical PSF and CMLE method. Maximum intensity projections (MIPs) of the fluorescence channel stacks were generated in Fiji56. For transmitted light data, one slice focused on the holes of the support film was selected and then used for the 2D-correlation procedure.
Cryo-electron tomography data acquisition and processing
TEM data acquisition was performed on a Krios G4 microscope at 300 kV with a Selectris X energy filter and Falcon 4i camera (Thermo Fisher Scientific) using Tomo5 (version 5.12.0, Thermo Fisher Scientific, RRID:SCR_021359, https://tomopy.readthedocs.io/). Tilt series were acquired at a nominal magnification of ×42,000 (pixel size, 2.93 Å) using a dose-symmetric tilt scheme with an angular increment of 2°, a dose of 2 e− Å−2 per tilt and a target defocus between −2.5 and −4 µm. Tilt series were collected from −60° to 60° with a total dose of 120 e− Å−2, and frames were saved in the EER file format. The positions for tilt-series acquisition were determined by visual inspection of ×11,500 magnification ‘search’ montage maps acquired in thin areas of the sample (Extended Data Fig. 3a). Tilt series were recorded where double-membrane vesicle structures could be seen inside intact iNeuron projections, with continuous plasma membrane and microtubules bundles. Most of the autophagosomes were captured in areas in which the sample was thicker than 400 nm (Extended Data Fig. 3o). Although such a high sample thickness is generally not recommended for subtomogram averaging of particles because of the low signal-to-noise ratio (SNR) of the resulting images, it still allowed neural-network-based segmentation and visualization of autophagosomes and their membrane cargo. The tilt-series frames were motion-corrected with Relion’s implementation of Motioncorr2 (Version 4.0, RRID:SCR_016499, https://emcore.ucsf.edu/cryoem-software) for EER files57, and reconstruction was performed in IMOD (v.4.10.49, RRID: SCR_003297, https://bio3d.colorado.edu/imod/) using the TomoMAN wrapper scripts https://doi.org/10.5281/ZENODO.4110737. Tomograms at 2× binning (IMOD bin 4) with a nominal pixel size of 1.172 nm were denoised using cryo-CARE58 (https://github.com/juglab/cryoCARE_T2T).
Cryo-electron tomography dataset annotation and analysis
All double-membrane compartments were relatively tight and had regular intermembrane spacing and near-spherical shapes were identified as autophagosomes. Note that although some autophagosomes presented a tight and homogeneous intermembrane distance (Extended Data Fig. 3n, autophagosomes 3 and 4), others presented variable intermembrane distances, or small bumps in the inner membrane (Fig. 5f), which might suggest that they are amphisomes—autophagosomes that have already fused with one or a few small lysosomes59. Thirty-two tomograms contained autophagosomes, and some of them contained more than one, leading to total count of 37 autophagosomes. All structures were first annotated by cargo. Tubular membrane cargo structures, morphologically similar to the ER tubules present in the cytoplasm of the same tomograms (Fig. 5c and Extended Data Fig. 3e), were labelled as ‘tubular ER cargo’. Note that the autophagosomes often contained single-membrane vesicle cargo next to the tubular ER (Fig. 5c,f and Extended Data Fig. 3n). Second, autophagosomes were annotated as ‘microtubule-linked’ when microtubules were found at a distance closer than 20 nm from their outer membrane (Extended Data Fig. 3f). Tomogram thickness was determined in 3Dmod (IMOD) by measuring the distance between the upper and lower boundaries of the sample, where small pieces of ice contamination are often visible (Extended Data Fig. 3o). Plots were generated with Python Programming Language (Version 3.9.7, RRID:SCR_008394, https://www.python.org/downloads/release/python-360/) using pandas 1.3.0 (https://pandas.pydata.org/, RRID: SCR_018214)60, Matplotlib 3.3.0 (https://matplotlib.org/,RRID:SCR_008624)61 and seaborn 0.11.0 (https://seaborn.pydata.org/, RRID: SCR_018132)62 packages.
2D correlation of cryo-fluorescence data on TEM images
Correlation of all autophagosomes with the previously acquired cryo-fluorescence data was investigated through a two-step procedure using Fiji’s BigWarp plugin (Version 9.0.0, https://github.com/saalfeldlab/bigwarp)63 as follows. First, the centres of different holes on the support film were selected both in a ×800 TEM ‘overview’ image and in a transmitted light image previously acquired on the cryo-confocal microscope (Extended Data Fig. 3g). After registration, the ×800 TEM image was transformed (affine transformation) and overlaid on the green and red fluorescence MIPs (Extended Data Fig. 3h). The overlay was then cropped to obtain a subregion around the tomogram position, which was used for the second correlation with the ×11,500 TEM ‘search’ image (Extended Data Fig. 3i). This time, fine landmarks such as pieces of ice, features of the cellular sample and positions along the hole were selected and used for transforming the cropped fluorescence data (affine transformation). A final overlay of the ×11,500 TEM search image with the cryo-fluorescence data was generated to visualize the correlation of the autophagosomes with the fluorescence signals (Extended Data Fig. 3k,m). This procedure yielded a total of n = 5 out of 37 autophagosomes coinciding with distinct TEX264-GFP signal peaks (Fig. 5b). All five tomograms coinciding with TEX264 contained tubular ER cargo, and four of them were in close proximity to microtubules (Extended Data Fig. 3l). Note that the LC3B cryo-fluorescence signal often appears diffuse and bright in the cytosol, and it was difficult to distinguish peaks of signal corresponding to the autophagic structures (Extended Data Fig. 3k,m). This might be due to LC3B also localizing on microtubules or being distributed throughout the cytosol and its involvement in other cellular processes, such as non-canonical autophagy33 and LC3-associated phagocytosis64. Consequently, the LC3B-mCherry signal could not be used for reliable cryo-correlation in this case. Moreover, extracellular debris, pieces of ice and other intracellular structures can often be autofluorescent at cryogenic temperatures in the green and/or red channels. This phenomenon has been reported previously by others and increases the noise in cryo-fluorescence images65.
Tomogram segmentation
Segmentations were carried out for the five tomograms of autophagosomes coinciding with the TEX264 signal. The membranes were segmented with Membrain-Seg (https://github.com/teamtomo/membrain-seg), a U-Net based tool for membrane segmentation in cryo-ET data, using the publicly available ‘best’ pretrained model (v9). This method reliably detects membranes, even in very thick tomograms (Extended Data Fig. 3n,o). However, it often merges membranes corresponding to different compartments and sometimes picks cytoskeletal components such as microtubules and neurofilaments in the very crowded neuronal subcellular environment. To separate the different membrane compartments, a watershed segmentation was performed on the original Membrain-seg output, using as seeds a ‘one-click’ rough segmentation of different membranes generated in Amira (Thermo Fisher Scientific) from the output of TomoSegMemTV66. For thicker tomograms, such as autophagosome 3 and 4 (Extended Data Fig. 3n,o), automated segmentations of the cargo ER were manually refined in Amira (Version 2021.2, https://www.thermofisher.com/id/en/home/electron-microscopy/products/software-em-3d-vis/amira-software.html). For autophagosomes 1 and 2 (Fig. 5c,f), microtubules were segmented automatically with Dragonfly (version 2022.2, Comet Technologies Canada, https://www.theobjects.com/dragonfly/index.html). A custom model was trained for each tomogram, following a previously described protocol67. 3D renderings of the segmentations were generated in UCSF ChimeraX (Version 1.6.1, RRID:SCR_015872, https://www.cgl.ucsf.edu/chimerax/)68.
Quantitative proteomics
Sample preparation for mass spectrometry
Cell pellets were resuspended in 8 M urea buffer (8 M urea, 150 mM Tris pH, 150 mM NaCl) supplemented with protease and phosphatase inhibitor tablets and then sonicated twice, 10 s each, on ice. The lysates were clarified by centrifugation at 20,000g for 10 min at 4 °C. BCA assays were performed on clarified lysates, then 100 μg of each sample was taken and the total volume increased to 100 μl total. The samples were reduced using TCEP (0.5 M for 30 min at room temperature) and alkylated (with chloroacetamide, 20 mM for 20 min at room temperature) before methanol-chloroform precipitation with 3:1 methanol, 1:1 chloroform and 2.5:1 water added. The aqueous and organic phases were separated by centrifugation for 5 min at 14,000g. Liquid around the protein layer was removed and this protein layer was washed with 1 ml of methanol and then pelleted for 5 min at 14,000g. The supernatant was removed. The pellets were then resuspended in 50 μl, 200 mM 4-(2-Hydroxyethyl)-1-piperazinepropanesulfonic acid, 4-(2-Hydroxyethyl)piperazine-1-propanesulfonic acid, N-(2-Hydroxyethyl)piperazine-N′-(3-propanesulfonic acid) (EPPS), pH 8.5. Peptide digestion was carried out using LysC (1:100) for 2 h at 37 °C, followed by trypsin (1:100) overnight, then 25 μl of the digested peptides were labelled by adding 5 μl 100% acetonitrile (ACN) and 7 μl of TMT reagent (20 mg ml−1 stock in ACN) for 2 h, and the reaction was quenched using hydroxylamine at a final concentration of 0.5% (wt/vol) for 20 min.
Basic pH reversed-phase HPLC
Samples were combined 1:1 such that each channel consisted of the same amount of peptide. The pooled peptide sample was desalted with a 100-mg Sep-Pak solid phase extraction column and then fractionated with basic pH reversed-phase (BPRP) HPLC. Fractionation was executed using an Agilent 1200 pump with an Agilent 300 Extend C18 column (3.5-μm particles, inner diameter of 2.1 mm and length of 250 mm). A 50-min linear gradient from 5% to 35% ACN in 10 mM ammonium bicarbonate pH 8 at a column flow rate of 0.25 ml min−1 was used for peptide fractionation. A total of 96 fractions were collected and then concatenated down to 24 superfractions, as described previously69. These 24 superfractions were divided into two sets of 12 non-adjacent superfractions and were acidified by adding formic acid to a concentration of 1%. One set of fractions (n = 12) were vacuum-centrifuged to near dryness, and each was desalted via StageTip, dried by vacuum centrifugation, and reconstituted in 5% acetonitrile, 5% formic acid before LC-MS/MS analysis.
Mass spectrometry data acquisition and processing
Mass spectrometric data were collected on an Orbitrap Fusion Lumos mass spectrometer coupled to a Proxeon NanoLC-1200 UHPLC and a FAIMSpro interface70. The 100-μm capillary column was pulled in-lab and packed with 35 cm of Accucore 150 resin (2.6 μm, 150 Å; Thermo Fisher Scientific). Peptides were eluted over a gradient (90 or 110 min) consisting of 5% ACN to 30% ACN in 0.125% formic acid. The scan sequence began with an MS1 spectrum (Orbitrap analysis, resolution 60,000, scan range 350–1,350 or 400–1,600 Th, automatic gain control (AGC) target set as ‘standard’, maximum injection time set to auto). SPS-MS3 analysis was used to reduce ion interference71,72. MS2 analysis consisted of collision-induced dissociation (CID) and quadrupole ion trap analysis (AGC 2 × 104, normalized collision energy (NCE) 35, q-value 0.25, maximum injection time 35 ms, isolation window 0.7 Th). Following the acquisition of each MS2 spectrum, we collected an MS3 spectrum in which multiple MS2 fragment ions were captured in the MS3 precursor population using an isolation waveform with multiple frequency notches. MS3 precursors were fragmented by higher-energy collisional dissociation (HCD) and analysed using the Orbitrap (NCE 55, AGC 1.5 × 105, maximum injection time 150 ms, resolution 50,000). We used the Real Time Search (RTS) using Orbiter73 with a Homo sapiens database (UniProt, downloaded August 2020) and we limited MS3 scans to two peptides per protein per fraction. A total of 24 RAW files were collected, with data for 12 non-adjacent superfractions acquired using a compensation voltage (CV) set of −40/−60/−80 V with a 1.25-s TopSpeed cycle used for each CV.
Spectra were converted to mzXML via MSconvert (Version 3.0, https://bio.tools/msconvert)74. Database searching included all H. sapiens entries from UniProt. The database was concatenated with one composed of all protein sequences in that database in reversed order. Searches were performed using a 50-ppm precursor ion tolerance for total protein level profiling. The product ion tolerance was set to 0.9 Da. These wide mass tolerance windows were selected to maximize sensitivity in conjunction with SEQUEST75 (v2.3.0.420) searches and linear discriminant analysis76,77. TMT labels on lysine residues and peptide N termini (+304.207 Da) and carbamidomethylation of cysteine residues (+57.021 Da) were set as static modifications, and oxidation of methionine residues (+15.995 Da) was set as a variable modification. Peptide-spectrum matches (PSMs) were adjusted to a 2% false discovery rate (FDR)78,79. PSM filtering was performed using a linear discriminant analysis, also as described previously77, and then assembled further to a final protein-level FDR of 2%79.
Proteomics data analysis
PSMs were filtered for summed SNR (SNR > 200) across the TMT plex and for precursor signals that contained an isolation purity of >0.5 of the MS1 isolation window. To normalize protein input across TMT channels, all PSM intensities were summed, and the total intensity per channel was sum normalized to the median summed intensity across the TMTpro plex. Protein intensities were generated by summing input-normalized TMT intensities for the constituent peptide PSMs80, serving as a weighted average quantification. Comparison among experimental conditions (n = 3–4 biological replicates) were conducted by performing a Student’s two-sided t-test of normalized log2-transformed protein TMT intensities. The resulting P values were adjusted for multiple hypothesis correction using the Benjamini–Hochberg approach81. For heatmap generation or linear model analysis, replicate protein report ion intensities were normalized to the mean of the biological replicates of either day 0 for the differentiation experiment or to WT control day-12 iNeuron replicates within a given TMTpro plex.
To conduct the linear regression analysis using a single model for the additive combinatorial ER receptor knockout TMT data, we incorporated indicators/dummy variables that can take on one of two possible numerical values (1: contains addition of an ER receptor knockout(s); 0: does not). All replicates were normalized to the mean of the WT control, which was centred at 0, essentially removing the intercept estimation (ꞵ0) from the model. This was because the TMT protein reporter intensities are not indicative of absolute abundance, and we are interested in understanding the fold change contribution from the addition of each ER receptor knockout. The following indicators/dummy variables and model are presented in Supplementary Note 1. In R using the lm function, the beta (ꞵ) coefficients and P values were extracted from the model, and the ꞵ coefficients and Benajmini–Hochberg81-adjusted P values were leveraged for downstream analysis and figure generation. One can interpret the ꞵTKO⟶QKO for instance as the average FC from the triple knockout to the quadruple knockout, due to the addition of TEX264 KO on the FAM134A−/−/B−/−/C−/− knockout cells.
Classifications of proteins to various organellar locations or functional groups were performed using manually curated databases from UniProt and are listed in the relevant Supplementary tables. Subcellular annotations were derived from ref. 26 with additional cytosol protein location designations from UniProt. ER high sheet and high curvature annotations were extracted from ref. 2.
Statistics and reproducibility
Proteomics data analysis was performed using R Project for Statistical Computing (Version 4.2.2, RRID:SCR_001905, https://www.r-project.org/) within the Rstudio IDE (2022.12.0 Build 353, Posit, RRID:SCR_000432 https://posit.co/). Data visualizations in the form of heatmaps, volcano plots, violin plots, protein abundance profiles and subcellular localization plots were generated using the following R packages: tidyverse (Version 2.0.0, RRID:SCR_019186 https://CRAN.R-project.org/package=tidyverse), dplyr (Version 1.0.10, RRID:SCR_016708 https://cran.r-project.org/web/packages/dplyr/index.html), cowplot (Version 1.1.1, RRID:SCR_018081, https://cran.r-project.org/web/packages/cowplot/index.html), pheatmap (Version 1.0.12, RRID:SCR_016418, https://www.rdocumentation.org/packages/pheatmap/versions/0.2/topics/pheatmap), stringr (Version 1.5.0, RRID:SCR_022813, https://stringr.tidyverse.org/), RColorBrewer (Version 1.1-3, RRID:SCR_016697) https://cran.r-project.org/web/packages/RColorBrewer/index.html), ggrepel (Version 0.9.2, RRID:SCR_017393, https://cran.r-project.org/package=ggrepel), ggplot2 (Version 3.4.1, RRID:SCR_014601, https://cran.r-project.org/web/packages/ggplot2/index.html), purr (Version 1.0.1, https://cran.r-project.org/package=purrr) and tibble (Version, 3.1.8, https://cran.r-project.org/package=tibble). For imaging statistics, GraphPad Prism (Version 9.5.0, RRID:SCR_002798, http://www.graphpad.com/) was used. Mean (for the number of ER structures per nuclei), mean (for the area of axonal ER structures), percent intact nuclei and percent TUNEL-negative nuclei values from each replicate differentiation experiment (n = 4 in each experiment) were compared between each knockout and WT using a Mann–Whitney test. For flow cytometry quantification, GraphPad Prism (9.5.0) was used. Each condition had three biological replicates. Brown–Forsythe and Welch one-way ANOVA and Dunnett’s T3 multiple comparisons test (assuming a Gaussian distribution) were used to compare each condition. For imaging and flow cytometry analysis, *P < 0.05; **P < 0.01 and ***P < 0.001. For proteomics datasets, the alpha used for FDR cutoffs was adjusted P < 0.05 to consider significance. To compare log2FCs for each organelle proteome to a random distribution, a randomized protein selection was generated (100 iterations) keeping the same number of proteins as the perspective organelle. The log2FC distribution of this random protein set was compared to the organelle log2FC distribution using a Kolmogorov–Smirnov test (two-sided). For analysis of violins, when calculating the degree of change of each ER compartment’s ꞵ values from no change (zero), a Wilcoxon one-sided test was used with Bonferroni P-value correction applied due to the multiple comparisons. For other analyses of violins comparing the log2FCs between two genotypes for each ER compartment, the comparison was made using paired Wilcoxon two-sided tests. All data figures were generated in Adobe Illustrator (Version CS515.0.0, RRID:SCR_010279, http://www.adobe.com/products/illustrator.html) using R (4.1.3), Rstudio IDE (2021.09.3 Build 396, Posit), Fiji Image J (V.2.0.0) and GraphPad Prism (9.5.0).
Unless stated otherwise, all quantitative experiments were performed in triplicate and averages with s.e.m. or s.d., as indicated in the legends. For proteomics experiments, we chose n = 2, 3 or 4 biological replicates given the limitation of the available TMT channels and as extensive work in the field has shown that this approach provides the necessary statistical significance. The number of replicates for all TMT experiments is shown in the schematic in the relevant figure. For flow-cytometry experiments, we analysed >10,000 cells with triplicate experiments, which showed consistent results throughout the replicates. Confocal microscopy experiments were performed in triplicate or quadruplicate with n biological replicated differentiations unless otherwise noted. The number of replicates for immunoblotting experiments is provided in the figure legends, which were performed in triplicate unless otherwise noted. The number of data points in each plot represents the number of replicates used.
Reporting summary
Further information on research design is available in the Nature Portfolio Reporting Summary linked to this Article.
Data availability
We used canonical protein entries from the human reference proteome database in our study (UniProt Swiss-Prot – 2019-01; https://ftp.uniprot.org/pub/databases/uniprot/previous_major_releases/release-2019_01/). The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDEpartner repository82 with the dataset identifiers PXD041069 (Supplementary Data Tables 2, 3, 5, 7 and 11) and PXD046646 (Supplementary Tables 4, 6, 8, 9 and 10). Representative tomograms are available in the Electron Microscopy Data Bank under the following accession codes: EMD-19346 (Fig. 5c–e) and EMD-19194 (Fig. 5f–h). Previously published proteomics data25 that were re-analysed in Fig. 1 are available under accession code MSV000087961. Data supporting the findings of this study are available from the corresponding author on request. Source data are provided with this paper. Additional source data for this Article can also be found at https://doi.org/10.5281/zenodo.10606989.
Code availability
Code for proteomics data analysis and relevant figure generation is available at https://doi.org/10.5281/zenodo.10606794 and on Github at https://github.com/harperlaboratory/iNeuron_ERphagy.git.
References
Westrate, L. M., Lee, J. E., Prinz, W. A. & Voeltz, G. K. Form follows function: the importance of endoplasmic reticulum shape. Annu. Rev. Biochem. 84, 791–811 (2015).
Zhang, H. & Hu, J. Shaping the endoplasmic reticulum into a social network. Trends Cell Biol. 26, 934–943 (2016).
Shibata, Y. et al. Mechanisms determining the morphology of the peripheral ER. Cell 143, 774–788 (2010).
Park, S. H. & Blackstone, C. Further assembly required: construction and dynamics of the endoplasmic reticulum network. EMBO Rep. 11, 515–521 (2010).
Gubas, A. & Dikic, I. ER remodeling via ER-phagy. Mol. Cell 82, 1492–1500 (2022).
Grumati, P., Dikic, I. & Stolz, A. ER-phagy at a glance. J. Cell Sci. 131, jcs217364 (2018).
Khaminets, A. et al. Regulation of endoplasmic reticulum turnover by selective autophagy. Nature 522, 354–358 (2015).
Smith, M. D. et al. CCPG1 is a non-canonical autophagy cargo receptor essential for ER-phagy and pancreatic ER proteostasis. Dev. Cell 44, 217–232 (2018).
An, H. et al. TEX264 is an endoplasmic reticulum-resident ATG8-interacting protein critical for ER remodeling during nutrient stress. Mol. Cell 74, 891–908 (2019).
Chino, H., Hatta, T., Natsume, T. & Mizushima, N. Intrinsically disordered protein TEX264 mediates ER-phagy. Mol. Cell 74, 909–921 (2019).
Fumagalli, F. et al. Translocon component Sec62 acts in endoplasmic reticulum turnover during stress recovery. Nat. Cell Biol. 18, 1173–1184 (2016).
Grumati, P. et al. Full length RTN3 regulates turnover of tubular endoplasmic reticulum via selective autophagy. eLife 6, e25555 (2017).
Liang, J. R., Lingeman, E., Ahmed, S. & Corn, J. E. Atlastins remodel the endoplasmic reticulum for selective autophagy. J. Cell Biol. 217, 3354–3367 (2018).
Chen, Q. et al. ATL3 is a tubular ER-phagy receptor for GABARAP-mediated selective autophagy. Curr. Biol. 29, 846–855 (2019).
Reggio, A. et al. Role of FAM134 paralogues in endoplasmic reticulum remodeling, ER-phagy, and collagen quality control. EMBO Rep. 22, e52289 (2021).
Hu, J., Prinz, W. A. & Rapoport, T. A. Weaving the web of ER tubules. Cell 147, 1226–1231 (2011).
Shibata, Y., Hu, J., Kozlov, M. M. & Rapoport, T. A. Mechanisms shaping the membranes of cellular organelles. Annu. Rev. Cell Dev. Biol. 25, 329–354 (2009).
Voeltz, G. K., Prinz, W. A., Shibata, Y., Rist, J. M. & Rapoport, T. A. A class of membrane proteins shaping the tubular endoplasmic reticulum. Cell 124, 573–586 (2006).
Bhaskara, R. M. et al. Curvature induction and membrane remodeling by FAM134B reticulon homology domain assist selective ER-phagy. Nat. Commun. 10, 2370 (2019).
Mochida, K. et al. Super-assembly of ER-phagy receptor Atg40 induces local ER remodeling at contacts with forming autophagosomal membranes. Nat. Commun. 11, 3306 (2020).
Gonzalez, A. et al. Ubiquitination regulates ER-phagy and remodelling of the endoplasmic reticulum. Nature 618, 394–401 (2023).
Kuijpers, M. et al. Neuronal autophagy regulates presynaptic neurotransmission by controlling the axonal endoplasmic reticulum. Neuron 109, 299–313 (2021).
Chang, C., Jensen, L. E. & Hurley, J. H. Autophagosome biogenesis comes out of the black box. Nat. Cell Biol. 23, 450–456 (2021).
Ghanbarpour, A., Valverde, D. P., Melia, T. J. & Reinisch, K. M. A model for a partnership of lipid transfer proteins and scramblases in membrane expansion and organelle biogenesis. Proc. Natl Acad. Sci. USA 118, e2101562118 (2021).
Ordureau, A. et al. Temporal proteomics during neurogenesis reveals large-scale proteome and organelle remodeling via selective autophagy. Mol. Cell 81, 5082–5098 (2021).
Itzhak, D. N., Tyanova, S., Cox, J. & Borner, G. H. Global, quantitative and dynamic mapping of protein subcellular localization. eLife 5, e16950 (2016).
Wu, Y. et al. Contacts between the endoplasmic reticulum and other membranes in neurons. Proc. Natl Acad. Sci. USA 114, E4859–E4867 (2017).
Liang, J. R. et al. A genome-wide ER-phagy screen highlights key roles of mitochondrial metabolism and ER-resident UFMylation. Cell 180, 1160–1177 (2020).
Tsuboyama, K. et al. The ATG conjugation systems are important for degradation of the inner autophagosomal membrane. Science 354, 1036–1041 (2016).
Wrighton, P. J. et al. Quantitative intravital imaging in zebrafish reveals in vivo dynamics of physiological-stress-induced mitophagy. J. Cell Sci. 134, jcs256255 (2021).
Stavoe, A. K. H. & Holzbaur, E. L. F. Autophagy in neurons. Annu. Rev. Cell Dev. Biol. 35, 477–500 (2019).
Evans, C. S. & Holzbaur, E. L. F. Quality control in neurons: mitophagy and other selective autophagy mechanisms. J. Mol. Biol. 432, 240–260 (2020).
Maday, S. & Holzbaur, E. L. Autophagosome biogenesis in primary neurons follows an ordered and spatially regulated pathway. Dev. Cell 30, 71–85 (2014).
Maday, S., Wallace, K. E. & Holzbaur, E. L. Autophagosomes initiate distally and mature during transport toward the cell soma in primary neurons. J. Cell Biol. 196, 407–417 (2012).
Zhang, Y. et al. Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron 78, 785–798 (2013).
Hickey, K. L. et al. Proteome census upon nutrient stress reveals Golgiphagy membrane receptor. Nature 623, 167–174 (2023).
An, H., Ordureau, A., Korner, M., Paulo, J. A. & Harper, J. W. Systematic quantitative analysis of ribosome inventory during nutrient stress. Nature 583, 303–309 (2020).
Nthiga, T. M., Kumar Shrestha, B., Lamark, T. & Johansen, T. The soluble reticulophagy receptor CALCOCO1 is also a Golgiphagy receptor. Autophagy 17, 2051–2052 (2021).
Nthiga, T. M. et al. CALCOCO1 acts with VAMP-associated proteins to mediate ER-phagy. EMBO J. 39, e103649 (2020).
Ishii, S. et al. CCPG1 recognizes endoplasmic reticulum luminal proteins for selective ER-phagy. Mol. Biol. Cell 34, ar29 (2023).
Sun, Z. & Brodsky, J. L. Protein quality control in the secretory pathway. J. Cell Biol. 218, 3171–3187 (2019).
Kumar, N. et al. VPS13A and VPS13C are lipid transport proteins differentially localized at ER contact sites. J. Cell Biol. 217, 3625–3639 (2018).
Wilkinson, S. Emerging principles of selective ER autophagy. J. Mol. Biol. 432, 185–205 (2020).
Huttlin, E. L. et al. Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. Cell 184, 3022–3040 e3028 (2021).
Shibata, Y. et al. The membrane curvature inducing REEP1 proteins generate a novel ER-derived vesicular compartment. Preprint at https://www.biorxiv.org/content/10.1101/2023.12.19.572386v1 (2023).
Wang, N., Shibata, Y., Paulo, J. A., Gygi, S. P. & Rapoport, T. A. A conserved membrane curvature-generating protein is crucial for autophagosome formation in fission yeast. Nat. Commun. 14, 4765 (2023).
Di Lorenzo, G. et al. Phosphorylation of FAM134C by CK2 controls starvation-induced ER-phagy. Sci. Adv. 8, eabo1215 (2022).
Chino, H. et al. Phosphorylation by casein kinase 2 enhances the interaction between ER-phagy receptor TEX264 and ATG8 proteins. EMBO Rep. 23, e54801 (2022).
Zuris, J. A. et al. Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo. Nat. Biotechnol. 33, 73–80 (2015).
Ordureau, A. et al. Global landscape and dynamics of Parkin and USP30-dependent ubiquitylomes in iNeurons during mitophagic signaling. Mol. Cell 77, 1124–1142 (2020).
Ordureau, A. et al. Dynamics of PARKIN-dependent mitochondrial ubiquitylation in induced neurons and model systems revealed by digital snapshot proteomics. Mol. Cell 70, 211–227 (2018).
Eapen, V. V., Swarup, S., Hoyer, M. J., Paulo, J. A. & Harper, J. W. Quantitative proteomics reveals the selectivity of ubiquitin-binding autophagy receptors in the turnover of damaged lysosomes by lysophagy. eLife https://doi.org/10.7554/eLife.72328 (2021).
McQuin, C. et al. CellProfiler 3.0: next-generation image processing for biology. PLoS Biol. 16, e2005970 (2018).
Yoshii, S. R. et al. Systemic analysis of Atg5-null mice rescued from neonatal lethality by transgenic ATG5 expression in neurons. Dev. Cell 39, 116–130 (2016).
van Schadewijk, A., van’t Wout, E. F., Stolk, J. & Hiemstra, P. S. A quantitative method for detection of spliced X-box binding protein-1 (XBP1) mRNA as a measure of endoplasmic reticulum (ER) stress. Cell Stress Chaperones 17, 275–279 (2012).
Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676–682 (2012).
Nakane, T. et al. Single-particle cryo-EM at atomic resolution. Nature 587, 152–156 (2020).
Buchholz, T. O., Jordan, M., Pigino, G. & Jug, F. Cryo-CARE: content-aware image restoration for cryo-transmission electron microscopy data. In Proc. IEEE 16th International Symposium on Biomedical Imaging (ISBI 2019) 502–506 (IEEE, 2019); https://doi.org/10.1109/ISBI.2019.8759519
Sidibe, D. K., Vogel, M. C. & Maday, S. Organization of the autophagy pathway in neurons. Curr. Opin. Neurobiol. 75, 102554 (2022).
McKinney, W. Data structures for statistical computing in Python. In Proc. 9th Python in Science Conference (eds van der Walt, S. & Millman, J.) 56–61 (2010).
Hunter, D. Matplotlib: a 2D graphics environment. Comput. Sci. Eng. 9, 90–95 (2007).
Waskom, M. seaborn: statistical data visualization. J. Open Source Softw. 6, 3021 (2021).
Bogovic, J. A., Hanslovsky, P. & Saalfeld, S. Robust registration of calcium images by learned contrast synthesis. In Proc. IEEE 13th International Symposium on Biomedical Imaging (ISBI) 1123–1126 (IEEE, 2016); https://doi.org/10.1109/isbi.2016.7493463
Kumar, A. V. & Mills, J. Non-canonical autophagy in aging and age-related diseases. Front. Cell Dev. Biol. 11, 1137870 (2023).
Carter, S. D. et al. Distinguishing signal from autofluorescence in cryogenic correlated light and electron microscopy of mammalian cells. J. Struct. Biol. 201, 15–25 (2018).
Martinez-Sanchez, A., Garcia, I., Asano, S., Lucic, V. & Fernandez, J. J. Robust membrane detection based on tensor voting for electron tomography. J. Struct. Biol. 186, 49–61 (2014).
Heebner, J. E. et al. Deep learning-based segmentation of cryo-electron tomograms. Jove https://doi.org/10.3791/64435-v (2022).
Meng, E. C. et al. UCSF ChimeraX: tools for structure building and analysis. Protein Sci. 32, e4792 (2023).
Paulo, J. A. et al. Quantitative mass spectrometry-based multiplexing compares the abundance of 5,000 S. cerevisiae proteins across 10 carbon sources. J. Proteom. 148, 85–93 (2016).
Saba, J., Bonneil, E., Pomies, C., Eng, K. & Thibault, P. Enhanced sensitivity in proteomics experiments using FAIMS coupled with a hybrid linear ion trap/Orbitrap mass spectrometer. J. Proteome Res. 8, 3355–3366 (2009).
Gygi, J. P. et al. Web-based search tool for visualizing instrument performance using the Triple Knockout (TKO) proteome standard. J. Proteome Res. 18, 687–693 (2019).
Paulo, J. A., O’Connell, J. D. & Gygi, S. P. A triple knockout (TKO) proteomics standard for diagnosing ion interference in isobaric labeling experiments. J. Am. Soc. Mass Spectrom. 27, 1620–1625 (2016).
Schweppe, D. K. et al. Full-featured, real-time database searching platform enables fast and accurate multiplexed quantitative proteomics. J. Proteome Res. 19, 2026–2034 (2020).
Chambers, M. C. et al. A cross-platform toolkit for mass spectrometry and proteomics. Nat. Biotechnol. 30, 918–920 (2012).
Eng, J. K., McCormack, A. L. & Yates, J. R. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J. Am. Soc. Mass Spectrom. 5, 976–989 (1994).
Beausoleil, S. A., Villen, J., Gerber, S. A., Rush, J. & Gygi, S. P. A probability-based approach for high-throughput protein phosphorylation analysis and site localization. Nat. Biotechnol. 24, 1285–1292 (2006).
Huttlin, E. L. et al. A tissue-specific atlas of mouse protein phosphorylation and expression. Cell 143, 1174–1189 (2010).
Elias, J. E. & Gygi, S. P. Target-decoy search strategy for mass spectrometry-based proteomics. Methods Mol. Biol. 604, 55–71 (2010).
Elias, J. E. & Gygi, S. P. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat. Methods 4, 207–214 (2007).
Plubell, D. L. et al. Extended multiplexing of tandem mass tags (TMT) labeling reveals age and high fat diet specific proteome changes in mouse epididymal adipose tissue. Mol. Cell Proteom. 16, 873–890 (2017).
Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57, 289–300 (1995).
Perez-Riverol, Y. et al. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res. 47, D442–D450 (2019).
Acknowledgements
This work was supported by a Harvard Medical School sponsored research project grant from Astellas Pharmaceuticals (to J.W.H.), from Aligning Science Across Parkinson’s (ASAP, Michael J Fox Foundation administering grant ASAP-000282 on behalf of ASAP and itself to J.W.H., B.A.S. and W.B.), NIH (R01NS083524, R01NS110395 to J.W.H.; R01GM132129 to J.A.P.), the Max Planck Society (B.A.S.) and the Harvard Medical School Cell Biology Initiative for Molecular Trafficking and Neurodegeneration. M.J.H. was supported by post-doctoral fellowships from Jane Coffin Childs and the Fred and Joan Goldberg Education Fund at Harvard Medical School. For the purpose of open access, the author has applied a CC-BY public copyright licence to the author accepted manuscript (AAM) version arising from this submission. We also thank the Harvard Electron Microscopy Core and the Nikon Imaging Center at Harvard Medical School for microscopy support.
Author information
Authors and Affiliations
Contributions
M.J.H. and J.W.H. conceived the study. M.J.H. performed proteomics, gene editing, cell line construction, biochemical assays, cell biology, imaging and informatic analyses. J.C.P. and Y.J. performed gene editing and cell line construction. I.R.S. and M.A.G.-L. performed informatic analysis of the proteomic data. J.A.P. provided proteomics support. C.C. and A.B. performed cryo-ET under the supervision of F.W., W.B. and B.A.S. The paper was written by J.W.H., M.J.H., C.C. and I.R.S., with input from all authors.
Corresponding author
Ethics declarations
Competing interests
J.W.H. is a consultant and founder of Caraway Therapeutics (a wholly owned subsidiary of Merck & Co) and is a member of the scientific advisory board for Lyterian Therapeutics. B.A.S. is a co-founding scientific advisory board member of Interline Therapeutics and on the scientific advisory boards of Biotheryx and Proxygen. W.B. holds additional appointments as an honorary Professor at the Technical University Munich and a Distinguished Professor at ShanghaiTech University and is a member of the Life Science Advisory Board of Thermo Fisher Scientific. The other authors declare no competing interests.
Peer review
Peer review information
Nature Cell Biology thanks Maurizio Molinari, Zhenyu Yue, and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data
Extended Data Fig. 1 Landscape of ER remodelling via autophagy during hESC differentiation to iNeurons in vitro.
a, Landscape of the ER proteome and the effect of autophagy on accumulation of individual proteins. The ER proteome (359 proteins, Supplementary Data Table 1) is organized into functional modules and protein attributes (involved in ER membrane curvature, ER-associated, ER-membrane, ER-Lumen or ER-phagy receptor) are indicated by the respective outline box colour (see inset legend). For proteins with transmembrane segments, the number of segments are indicated after the protein name (_1, _2, etc) based on data in Uniprot. The text of each protein name is coloured based on day12 ATG12−/− vs WT Log2FC (see inset legend). (Supplementary Data Table 3). b, Changes in the abundance of the ER proteome (267 detected proteins) during conversion of WT hESCs to iNeurons are shown in as heatmaps (Log2FC) at the indicated day of differentiation relative to hESCs. Data are from our previous analysis of iNeuron differentiation. Annotations of the type of ER protein are indicated by the relevant colours. c, hESCs were differentiated to iNeurons and stained with antibodies against CKAP4 enriched in ER sheets (magenta) and RTN4 enriched in ER-tubules (green) at day 0, 4 and 12 of one differentiation. RTN4 staining is evident throughout neuronal projections. Scale bar, 100 microns in full images, 25 microns in all zooms. d, Violin plots for relative abundance of proteins located in the indicated organelles in ATG12−/− versus WT day 12 iNeurons. e, Immunoblots of cell extracts from WT or ATG12 −/− hESCs for the indicated day of differentiation for one differentiation. Blots were probed with the indicated antibodies, with α-HSP90 employed as a loading control. f, For the immunoblots in e, relative levels of each protein to HSP90 were quantified. Source numerical data and unprocessed blots are available in source data.
Extended Data Fig. 2 Quality control of in vitro neurogenesis methods.
a, The indicated hESCs were either cultured in the pluripotent state (day 0) or converted to day 12 iNeurons prior to total proteome analysis by multiplex TMT in biological triplicate cultures (n=3). The relative abundance (Log2 FC) of the indicated neurogenesis or pluripotency factors at day 12 relative to day 0 is shown, indicating that all genotypes undergo differentiation to a similar extent as measured by markers of the process. b, Comparable number of viable iNeurons were observed upon quantitative analysis of intact DAPI-positive nuclei compared to all DAPI-positive (intact and fragmented) DNA structures in cultures of the indicated genotypes. Four points shown for each WT or KO condition represent the measured ratios from the same four independent differentiations also analysed for ER structure per nuclei in Fig. 2b. Data are presented as mean values +/-SEM. *, p<0.05, two sided Mann–Whitney test. c,d Quantification of DAPI -positive TUNEL-negative nuclei in day 20 iNeurons from the indicated genotypes (c) and representative images of DAPI-positive nuclei in green and TUNEL-stained DAPI-positive fragmented nuclei, with TUNEL signal in magenta (d). The lower panels are magnified regions (merges and separate image channels) of the area boxed in the respective image above. Four points shown for each WT or KO condition represent the measured values from four independent differentiations. Data are presented as mean values +/-SEM. *, p<0.05, two sided Mann–Whitney test. Scale bar, 100 microns (top), 10 microns (bottom) e, ATF4 abundance was examined by immunoblotting of extracts from day 12 iNeurons from the indicated genotypes with or without treatment with tunicamycin as a positive control for induction of the ER-stress stress response. Tunicamycin was used at 0.1 or 1.0 μg/ml for 6 or 12 h, as indicated. Blots were reprobed with α-tubulin as a loading control. The relative α-ATF4 signal, normalized for tubulin, is shown in the histogram (right panel) with the dashed line representing ATF4 signal in untreated WT cells. n=1. f, XBP1 and XBP1s mRNA from the indicated iNeurons in biological triplicate (n=3) cultures was subjected to reverse transcription-PCR (see Methods) and examined by agarose gel electrophoresis to resolve spliced and unspliced XBP1. 1.0 μg/ml tunicamycin (6h) was employed as a positive control for induction of ER stress and XBP1 splicing. GAPDH was used as a positive control. The XBP1s/XBP1 ratio was quantified as shown in the histogram (right panel). No evidence of increased XBP1 splicing was observed in any genotype under untreated conditions. Data are presented as mean values +/-SEM. *, p<0.05; **, p<0.01; n.s., not significant; Brown–Forsythe and Welch One-way ANOVA and Dunnett’s T3 multiple comparisons test. g, TEX264-GFP, TEX264F273A-GFP, or FAM134C-GFP were expressed in WT or ATG12−/− hESCs and cells imaged at day 4 of differentiation to iNeurons. In some experiments, VPS34i was added to WT cells for 24h prior to imaging. Arrows mark examples of ER-phagy receptor puncta. h, Expression of TEX264-GFP was verified by immunoblotting of iNeuron extracts using α-HSP90 as a loading control. i, Number of TEX264-GFP puncta was quantified in day 4 iNeurons (n = 1 independent differentiation). Min-to-max box-and-whiskers representing detectable number of puncta per cell, with box representing the 25th to 75th percentile, whiskers going from min to max values, line at median and + at mean. j, Day 30 iNeurons expressing TEX264-GFP and mCh-LC3B were immunostained with α-MAP2 to detect dendrites (white) and α-NEFH to mark axons (blue) and projections imaged by confocal microscopy. One differentiation was fixed and imaged this way. Insets show TEX264-GFP/mCh-LC3B-positive puncta (arrows) or mCh-LC3B-positive but TEX264-GFP-negative puncta (arrowheads) in axons. All scale bars, 10 microns. Source numerical data and unprocessed blots are available in source data.
Extended Data Fig. 3 Analysis of autophagosomes in iNeurons by correlative cryo-ET.
a,125X TEM image of the grid used in this study from one differentiation experiment. The yellow square indicates the region shown in b. b, 800X TEM overview of a grid square. The darker area corresponds to the thicker iNeuron cell bodies; around it, many thinner projections corresponding to axon and dendrites can be observed. The white square indicates a particular area rich in neuronal projections, shown in c. c, 11500X TEM montage acquired to map a potentially interesting area. Extracellular vesicles are also present (white dashed circles). Pieces of ice are sitting on top of the frozen sample (asterisks). Autophagosome 1 (AP) was found in this area. d, Slice of the tomogram of autophagosome 1, denoised with Cryo-CARE. Scale bar, 200 nm. e, 3D rendering of autophagosome 1 with manually refined segmentations of a cytosolic ER tubule (dark green) and a portion of the tubular ER cargo (yellow). f, Cumulative barplot showing number of autophagosomes containing tubular ER cargo (n=21), linked to microtubules (n=24) or both (n=14). g, Example of the 2D-correlation workflow for autophagosome 1. Correlation of the 800X TEM overview with cryo-confocal data, represented by a single in-focus slice of the transmitted light stack (cyan) and maximum intensity projection (MIP) of fluorescence channels. The coloured dots indicate the position of the 2 µm holes that were selected in both images for 2D-registration. After 2D registration, the TEM overview is transformed to match the fluorescence data. h, Overlay of the fluorescence data with the transformed TEM overview. The white square indicates the cropped area used for the second step of the correlation procedure. i, 11500X TEM image of the area around autophagosome 1. The coloured dots indicate features of the image that were used for finer correlation with the cropped fluorescence data. j, Cropped fluorescence data corresponding to the square in g. The colored dots indicate the same correlation points shown in h. The fluorescence data is subsequently transformed to match the 11500X TEM image. k, Final overlay of the fluorescence data over the 11500X TEM image. The white square represents the tomogram position. l, Cumulative barplot showing number of TEX264-GFP positive autophagosomes that contain ER tubular cargo (n=5) and are linked to microtubules (n=4). m, 11500X TEM and fluorescence overlays for TEX264-GFP-positive autophagosomes 2, 3, 4 and 5. n, 3D segmentations, zoomed-in 11500X TEM images overlaid with GFP cryo-fluorescence signal and cryo-CARE denoised slices for autophagosomes 3, 4, and 5. All images are rotated right by 90 degrees compared to their respective full 11500X overlays in m. Autophagosome 3 and 4 are microtubule-linked, while autophagosome 5 is distant from the microtubules (MT). o, Plot showing thickness of all tomograms (n=32) analysed in this work. Each dot represents a tomogram. Black dots indicate the tomograms corresponding to the five TEX264-GFP-positive autophagosomes (AP) shown in this study.
Extended Data Fig. 4 Generation of a genetic toolkit for functional analysis of ER-phagy receptors in iNeurons.
a, MiSeq analysis of single ER-phagy receptor mutants in hESCs. The green highlights the target of the CRISPR gRNA. The sequence of the major MiSeq output is indicated for each allele. b, Immunoblot validation of targets knockout clones at day 12 of differentiation. Confirmation immunoblots for protein deletion in these different genetic backgrounds were performed for each proteomics experiment. Cell extracts were subjected to immunoblotting with the indicated antibodies, employing a Rhodamine-labelled α-tubulin as loading controls. *, position of the ATG12-ATG5 conjugate. c, MiSeq analysis of combinatorial ER-phagy receptor mutants in hESCs, as performed for the single knockouts in a. d, Immunoblot validation of targets in combinatorial knockout clones at day 12. Cell extracts were subjected to immunoblotting as in b. Confirmation immunoblots for protein deletion in these different genetic backgrounds were performed for each proteomics experiment. e, Karyotype analysis of QKO and PKO hESCs revealed no detectable alterations in chromosome number. f, Ratiometric flow cytometry analysis of Keima-RAMP4 flux was measured in WT, ATG12−/−, or the indicated ER-phagy receptor knockout ES cells (day 0 of differentiation). The ratio of acidic to neutral Keima fluorescence was normalized to samples treated with BAFA (100 nM) for 4 h prior to analysis, and where indicated, cells were cultured with VPS34i prior to analysis. Each measurement (represented by a point) reflects a biological triplicate sample. g, As in panel f, but at day 4 of differentiation to iNeurons. For f, and g, Data are presented as mean values +/−SD. n.s., not significant; Brown–Forsythe and Welch One-way ANOVA and Dunnett’s T3 multiple comparisons test. h, Day 12 iNeurons treated Propidium iodine staining and were analysed via flow cytometry. The same gating strategy for live cells was applied to all genotypes, as was done in all Keima flux experiments. Mean values +/-SEM of the percent of live cells (not stained with PI) is displayed. N=3 biological replicates; n.s. not significant; two sided Mann–Whitney test. i, Examples of enlarged axonal structures from WT, ATG12−/− and PKO day 30 iNeurons containing dense tubular ER, as visualized by TEM. Some of these examples were also shown in Fig. 2 to compare only WT and ATG12−/−. Three independent examples are shown. Scale bar, 500nm. Source numerical data, flow cytometry gating strategy, and unprocessed blots are available in source data.
Extended Data Fig. 5 Combinatorial analysis of ER remodelling via ER-phagy receptors during neurogenesis in vitro.
a, Violin plots for changes in individual organelle abundance in the indicated single ER-phagy knockout iNeurons (day 12). b, Violin plots for changes in individual organelle abundance in the indicated combinatorial ER-phagy knockout iNeurons (day 12). c, Log2FC (mutant/WT) distributions of ER proteins (top), Golgi proteins (middle), or mitochondria proteins (bottom) compared to randomized selections of the same number of proteins (100 iterations). p-values for each comparison are calculated with a Kolmogorov–Smirnov Test (two-sided). The ER protein section of the figure (top panel) is reproduced from Fig. 7c. d, Correlation plots for changes in organelle abundance (Log2FC) comparing DKO, TKO, QKO and PKO log2FCs from WT individually with ATG12−/− log2FCs from WT.
Extended Data Fig. 6 Analysis of ER-proteome remodelling in PKO and CALCOCO1−/− iNeurons.
a, Proteomic analysis of two PKO clones (A2 and E4) in parallel with ATG12−/− and WT iNeurons (day 20). The upper panel provides a schematic of the TMT multiplex approach employed. n = 4 biological replicates. Middle panel displays Log2FC for ER protein and selected ER protein categories. Lower panel displays Log2FC for the indicated organelles. b, Heatmap for Log2FC values for the indicated proteins from the experiment in panel a. c, Immunoblot validating deletion of FAM134B, FAM134C, TEX264, and CCPG1 in both clone A2 and E4 for the PKO mutant. d, Modulation of iNeuron proteome in response to inhibition of MTOR with Torin1 (100 nM,15 h). Upper panel shows a schematic of the experimental set-up employing TMT based proteomics to quantity alterations in the proteome if WT or ATG12−/−, PKO iNeurons. Lower panel: Correlation plots comparing the effect of Torin1 on organelles of ATG12−/− cells relative to WT cells and PKO cells relative to WT cells. e, MiSeq analysis of a CALCOCO1−/− H9 hESC clone, showing the position of the gRNA used for CRISPR-Cas9 deletion, and the position of out of frame deletions in the two alleles of CALCOCO1. f, Schematic showing the TMT total proteome strategy for analysis of the effect of CALCOCO1 deletion on organelle abundance in hESCs and day 12 iNeurons (n=3 biological replicates). ATG12−/− cells were included as a positive control. g, Heatmap of Log2FC values for selected proteins from the TMT experiment outlined in panel f, which also demonstrates loss of the CALCOCO1 protein in the CALCOCO1−/− iNeurons. h, Violin plots (Log2FC) for the indicated organelles (top panel) and selected classes of ER proteins (lower panel) for ATG12−/− and CALCOCO1−/− iNeurons (day 12). Loss of CALCOCO1 does not affect the abundance of any of the organelles tested. i, Comparison of Log2FC (mutant/WT) distributions of ER proteins (top) or Golgi proteins (bottom) to distributions of randomized selections of the same number of proteins (100 iterations). p-values for comparisons were calculated with a Kolmogorov–Smirnov Test (two-sided). Unprocessed blots are available in source data.
Extended Data Fig. 7 Overview of ER proteome remodeling via ER-phagy receptors during neurogenesis in vitro.
a, Changes in the abundance (Log2FC) of the ER proteome (267 detected proteins) during conversion in ATG12−/− or combinatorial ER-phagy receptor knockout iNeurons (day 12) are shown as heatmaps. Annotations of the type of ER protein are indicated by the relevant colours. b, Landscape of the ER proteome and the effect of deletion of five ER-phagy receptors (FAM134A/B/C, TEX263 and CCPG1) on accumulation of individual proteins. The ER proteome (359 proteins, Supplementary Data Table 1) is organized into functional modules, and protein attributes (involved in ER membrane curvature, ER-associated, ER-membrane, ER-Lumen or ER-phagy receptor) are indicated by the respective outline box colour (see inset legend). For proteins with transmembrane segments, the number of segments is indicated after the protein name (_1, _2, etc) based on data in Uniprot. The text of each protein name is colored based on day12 PKO vs WT Log2FC (see inset legend). (Supplementary Data Table 3).
Extended Data Fig. 8 Application of a linear model for alterations in ER proteome abundance in sequential ER-phagy receptor knockout cells during iNeuron differentiation.
a, Effect of sequential ER-phagy receptor deletion on the β coefficient values for individual organelles measured by quantitative proteomics in day 12 iNeurons. b, Violin plots reflecting changes in β coefficient values for individual organelles measured by quantitative proteomics in day 12 iNeurons. Curved arrows reflect sequential removal of the indicated ER-phagy receptor. c, Correlation plots for the indicated β coefficient or Log2FC plots comparing organelle abundance for combinatorial or single ER-phagy deletion iNeurons. d, Experiment characterizing FAM134C−/−, FAM134A/C−/−, and FAM134B/C−/− day 12 iNeurons with ATG12−/− iNeurons included as a control. Top left, Immunoblot of extracts from iNeurons of the indicated genotypes (n = 3) were probed with α-ATG5, α-FAM134B, α-FAM134C, or α-tubulin. ATG12−/− cells display loss of the ATG12-ATG5 conjugate as observed with α-ATG5. Top right, experimental scheme for multiplexed total proteome analysis of FAM134C−/−, FAM134A/C−/−, and FAM134B/C−/− iNeurons and ER proteome specific violin plots derived from this analysis. Bottom, organelle-specific violin plots from the experiment. p-values for comparisons between violins were calculated using paired two sided Wilcoxon tests. Unprocessed blots are available in source data.
Extended Data Fig. 9 Differential regulation of ER membrane shaping and disease-linked proteins upon loss of ER-phagy receptors.
a, Heatmaps displaying Log2 FC values for selected ER-shaping proteins for the indicated iNeuron genotypes. b, Heatmaps displaying Log2 FC values for Hereditary Spastic Paraplegia (HSP)-linked proteins or Hereditary Sensory and Autonomic Neuropathy (HSAN)-linked proteins for the indicated iNeuron genotypes. c, Immunoblot of extracts from WT, ATG12−/−, or PKO day 12 iNeurons (n=3) were probed with α-REEP1, α-REEP5, α-RTN3 or α-tubulin as a loading control (blot1) or were probed with α-RTN1C, α-VAPA or α-tubulin as a loading control (blot2). The relative levels of each protein to tubulin were quantified (right). Data are presented as mean values +/-SEM. d-e, Further examples ER shaping proteins that accumulate (d) or decrease (e) with additional ER-phagy receptor knockout. f, Immunoblot of cell extracts isolated from the indicated time point during differentiation (n=1), using α-HSP90 as a loading control. The relative levels of proteins were quantified (right). g, Immunoblot of extracts from WT or FAM134A/C−/− (DKO) iNeurons with or without expression of FAM134C-GFP using a PiggyBac vector (n = 3). Blots were probed with α-TEX264, α-REEP1, α-REEP4 or α-tubulin as a loading control. The relative levels of proteins to tubulin were quantified in the lower panel. Data are presented as mean values +/-SEM. h, Experimental scheme for multiplexed total proteome analysis of WT or FAM134A/C−/− with or without expression of FAM134C-GFP iNeurons (n = 3) and ER protein-specific violin plots derived from this analysis. p-values for comparisons between violins were calculated using paired two sided Wilcoxon tests. i, Heatmap displaying Log2 FC values for selected ER-shaping proteins for the indicated iNeuron genotypes. Source numerical data and unprocessed blots are available in source data.
Extended Data Fig. 10 Differential regulation of ER membrane shaping proteins upon loss of ER-phagy receptors.
a, ER lumenal proteins that accumulate with additional ER-phagy receptor knockout. Top panels are β coefficient values and lower panels are Log2FC; green asterisks in β coefficient for single protein heatmaps indicate significant change (adjusted p-value < 0.05) in β coefficient. b, ER lumenal protein heatmaps reflecting the change in abundance (Log2FC) for deletion of ATG12 or PKO, reflecting β coefficient values for QKO to PKO, (left panel) or reflecting the change in abundance (Log2FC) for single deletion of CCPG1 (right panel). c, Experimental scheme for multiplexed total proteome analysis of WT, ATG12−/− or TEX264−/−/CCPG1−/− iNeurons (n = 3) and violin plots for total ER, ER-lumen, and ER-membrane proteins derived from this analysis. Violin plots from a TMT 18-plex experiment comparing WT, ATG12−/−, and another ER-phagy receptor allelic combination (TEX264−/− +CCPG1−/−) with complementary comparisons of Log2FC (mutant/WT) distributions of ER proteins (top), ER lumenal proteins (middle), or ER membrane proteins (bottom) to distributions of randomized selections of the same number of proteins (100 iterations). p-values for each comparison are calculated with a Kolmogorov–Smirnov Test (two-sided) test. Together these reflect accumulation of the ER, ER lumen and ER membrane for Log2FC (ATG12−/−/WT) but only the ER lumenal proteome accumulates for Log2FC (TEX264−/− +CCPG1−/− /WT). d, ER contact site protein VAPB accumulates with additional ER-phagy receptor knockout. Plot is annotated as in panel a.
Supplementary information
Supplementary Information
Supplemental note with formulae.
Supplementary Video 1
Image sequence played at 2 frames per second. Circles indicate co-trafficking of TEX264-GFP/mCh-LC3B positive puncta. Scale bar, 10 μm.
Supplementary Video 2
This example movie includes the cropped region represented in Fig. 4d. Image sequence played at 2 frames per second. Circles indicate co-trafficking FAM134C-GFP/mCh-LC3B positive puncta. Scale bar, 10 μm.
Supplementary Video 3
This example movie is the region represented in Fig. 4e where a TEX264-GFP/mCh-LC3B positive puncta leaves the dilated axonal region. Image sequence played at 2 frames per second. Scale bar, 5 μm.
Supplementary Video 4
See text for details.
Supplementary Tables
Supplementary Table 1. ER protein designation table. The ER proteome (359 proteins) is organized into functional modules and protein attributes (involved in ER membrane curvature, ER-associated, ER-membrane, ER-lumen or ER-phagy receptor). For proteins with transmembrane segments, the number of segments is indicated after the protein name (_1, _2, and so on) based on data in UniProt. Relevant to assigning ER designations in all other Supplementary Data tables. In .xlsx format.
Supplementary Table 2. Total proteome analysis for hESC conversion to iNeurons, WT day 0 to day 12. Relevant to Fig. 1a,b and Extended Data Fig. 1b. In .xlsx format. Details of the experiment underlying these data are provided in a tab in the table. P values corresponding to individual protein log2FCs were calculated with a Student’s t-test (two-sided) and adjusted for multiple hypothesis correction using the Benjamini–Hochberg approach.
Supplementary Table 3. Total proteome analysis for WT, ATG12−/−, DKO, TKO, QKO, PKO day12 iNeurons. ATG12−/− versus WT relevant to Fig. 1c–e and Extended Data Fig. 1a. ATG12−/−, DKO, TKO, QKO, PKO versus WT relevant to Figs. 7b–g, 8a–c,e,f; Extended Data Figs. 5b–d, 7, 8a–c, 9a,b,d, 10a,b,d. In .xlsx format. Details of the experiment underlying the data are provided in a tab in the table. P values corresponding to individual protein log2FCs were calculated with a Student’s t-test (two-sided) and adjusted for multiple hypothesis correction using the Benjamini–Hochberg approach.
Supplementary Table 4. Total proteome analysis for WT, ATG12−/−, PKO day 0 ESC and day12 iNeurons. Relevant to Extended Data Fig. 2a. In .xlsx format. Details of the experiment underlying the data are provided in a tab in the table. P values corresponding to individual protein log2FCs were calculated from a Student’s t-test (two-sided) and adjusted for multiple hypothesis correction using the Benjamini–Hochberg approach.
Supplementary Table 5. Total proteome analysis for WT, ATG12−/−, CCPG1−/−, TEX264−/−, FAM134A−/−, FAM134B−/− and FAM134C−/− day-12 iNeurons. Relevant to Fig. 7a and Extended Data Figs. 5a, 8c, 9a, 10b. In .xlsx format. Details of the experiment underlying the data are provided in a tab in the table. P values corresponding to individual protein log2FCs were calculated from a Student’s t-test (two-sided) and adjusted for multiple hypothesis correction using the Benjamini–Hochberg approach.
Supplementary Table 6. Total proteome analysis for WT, ATG12−/−, PKOcloneA2 and PKOcloneE4 day-20 iNeurons. Relevant to Extended Data Fig. 6a–c. In .xlsx format. Details of the experiment underlying the data are provided in a tab in the table. P values corresponding to individual protein log2FCs were calculated from a Student’s t-test (two-sided) and adjusted for multiple hypothesis correction using the Benjamini–Hochberg approach.
Supplementary Table 7. Total proteome analysis for WT, ATG12−/− and PKO day-12 iNeurons with and without Torin1 inhibitor. Relevant to Extended Data Fig. 6d. In .xlsx format. Details of the experiment underlying the data are provided in a tab in the table. P values corresponding to individual protein log2FCs were calculated from a Student’s t-test (two-sided) and adjusted for multiple hypothesis correction using the Benjamini–Hochberg approach.
Supplementary Table 8. Total proteome analysis for WT, ATG12−/− and CALCOCO1−/− day-0 and day-12 iNeurons. Relevant to Extended Data Fig. 6e–i. In .xlsx format. Details of the experiment underlying the data are provided in a tab in the table. P values corresponding to individual protein log2FCs were calculated from a Student’s t-test (two-sided) and adjusted for multiple hypothesis correction using the Benjamini–Hochberg approach.
Supplementary Table 9. Total proteome analysis for WT, ATG12−/−, FAM134C−/−, FAM134CA−/−(DKO) and FAM134CB−/− day-12 iNeurons. Relevant to Extended Data Fig. 8d. In .xlsx format. Details of the experiment underlying the data are provided in a tab in the table. P values corresponding to individual protein log2FCs were calculated from a Student’s t-test (two-sided) and adjusted for multiple hypothesis correction using the Benjamini–Hochberg approach.
Supplementary Table 10. Total proteome analysis for WT, WT+FAM134C-GFP, FAM134CA−/−(DKO) and FAM134CA−/−(DKO)+FAM134C-GFP day-12 iNeurons. Relevant to Extended Data Fig. 9g–i. In .xlsx format. Details of the experiment underlying the data are provided in a tab in the table. P values corresponding to individual protein log2FCs were calculated from a Student’s t-test (two-sided) and adjusted for multiple hypothesis correction using the Benjamini–Hochberg approach.
Supplementary Table 11. Total proteome analysis for WT, ATG12−/− and TEX264−/−+CCPG1−/− day-12 iNeurons. Relevant to Extended Data Fig. 10c. In .xlsx format. Details of the experiment underlying the data are provided in a tab in the table. P values corresponding to individual protein log2FCs were calculated from a Student’s t-test (two-sided) and adjusted for multiple hypothesis correction using the Benjamini–Hochberg approach.
Source data
Source Data Extended Fig. 1
Unprocessed western blots.
Source Data Extended Fig. 2
Unprocessed western blots.
Source Data Extended Fig. 4
Unprocessed western blots and flow cytometry gating strategy.
Source Data Extended Fig. 6
Unprocessed western blots.
Source Data Extended Fig. 8
Unprocessed western blots.
Source Data Extended Fig. 9
Unprocessed western blots.
Source Data Fig. 7
Proteomics barplot ratio check and normalization strategy.
Source Data Statistical Extended Data Fig. 1
Statistical source data for Extended Fig. 1.
Source Data Statistical Extended Data Fig. 2
Statistical source data for Extended Fig. 2.
Source Data Statistical Extended Data Fig. 4
Statistical source data for Extended Fig. 4.
Source Data Statistical Extended Data Fig. 9
Statistical source data for Extended Fig. 9.
Source Data Statistical Fig. 2
Statistical source data for Fig. 2.
Source Data Statistical Fig. 3
Statistical source data for Fig. 3.
Source Data Statistical Fig. 4
Statistical source data for Fig. 4.
Source Data Statistical Fig. 6
Statistical source data for Fig. 6.
Source Data Statistical Fig. 8
Statistical source data for Fig. 8.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Hoyer, M.J., Capitanio, C., Smith, I.R. et al. Combinatorial selective ER-phagy remodels the ER during neurogenesis. Nat Cell Biol 26, 378–392 (2024). https://doi.org/10.1038/s41556-024-01356-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41556-024-01356-4
This article is cited by
-
ER remodelling by ER-phagy in neurogenesis
Nature Cell Biology (2024)